10 Landslidei
10 Landslidei
Citations:
Please note: citations are provided as a general guideline. Users should consult their preferred
citation format's style manual for proper citation formatting.
-- Your use of this HeinOnline PDF indicates your acceptance of HeinOnline's Terms and
Conditions of the license agreement available at
https://heinonline.org/HOL/License
-- The search text of this PDF is generated from uncorrected OCR text.
-- To obtain permission to use this article beyond the scope of your license, please use:
Copyright Information
JUST PUBLISHED
October, 2017 A LT
Long Beach, CA
WHEN
INHERENCY
DOES NOT
MEAN OBVIOUS
Also:
• Sovereign Immunity for Patents
• Navigating ODP
• Motivation to Combine a Decade
ater KSR
• IP Attachés
33rd Annual Intellectual Property Law Conference
April 18-20, 2018 Arlington, VA
Network FTC Best Practices for Brands & Social Media Inluencers
Hot Topics from the USPTO
Emerging Technologies – Regulatory or Ethical Issues?
US Copyright Ofice Update
Global Patent Law Survey 2018
Prosecuting and Defending Non-Use Abandonment Proceedings
The Right of Publicity: Property, Privacy, Personality, or Confusion?
Growing Your Start-Up IP Practice
Fictional Characters in 3D: What IP Rights Exist and Who Owns Them?
Multijurisdictional Practice and the Modern IP Atorney
Friday, April 20
Standards Essential Patents & the Internet of Things
Ethical Issues in Trademark Investigations
International Copyright Transactions
A
t the start of each new Congress, from our Section’s policy-making par- went to work with a team of volunteer
politicians return to our nation’s ticipants, our membership, or the HOD. experts from our patent, trademark, copy-
capital to chart the nation’s Such a requirement would be an unwork- right, and IP practice divisions to develop
agenda, and policy wonks and regula- able straitjacket. But as we formulate a a position for consideration by Section
tors contemplate their game plans for position, we consistently aim to stay true Council. Because our China issues and
executive, congressional, and regulatory to a couple of fundamental principles: antitrust committees had been working
action. So too does the ABA-IPL Section identifying policy that supports the long- extensively with the ABA’s Antitrust Sec-
spring into action. We analyze and pri- term health of the intellectual property tion for several years on comments to the
oritize key issues and, where warranted, (IP) system and what constitutes objec- Chinese government on its Anti-Monop-
begin making plans to appear before tive, conlict-free, and helpful positions oly Guidelines on IP Abuses, we were well
and/or submit written comments—to that best advance the more immediate positioned to speak from an informed per-
the US Patent and Trademark Ofice issues we have an opportunity to address. spective. Intensive work by our experts
(USPTO), the US Copyright Ofice, the Also, as the reality of the IP marketplace resulted in draft comments and an impres-
International Trade Commission and and its legal structure change, we some- sive 10-page recommendation prepared for
other federal and international agen- times opt to change previous policies and Council’s urgent consideration. A draft let-
cies, Congress, and the executive branch. adapt to the times. But we always remain ter was then submitted to other Sections of
Even before a new president takes ofice, cognizant that, when the ABA-IPL Sec- the ABA, including the Antitrust and Inter-
the Section typically has submitted a list tion speaks for the ABA, our use of the national Law Sections. As is customary for
of priorities to the presidential transition ABA moniker gives us both a special seat this kind of commentary, the other ABA
team, as we did last December. at the table and immense credibility. As a Sections then had the option of suggesting
How does our Section establish pol- result, we do not speak on every issue; we changes and objections to the letter before
icy, and then implement it? We start at choose when our voice will matter most. it could be sent to the USTR. With this part
the grassroots—our committees and sub- And we are careful to make our views of the process complete, our Section was
committees, and sometimes specialized known with a measured frequency that able to submit comments by letter1 and to
task forces. They and the oficers identify helps underscore, instead of dilute, the testify2 before the USTR and other depart-
issues, but the work of analyzing issues importance of the ABA voice. ments of the executive branch.
and drafting a proposed Section position How we go about ensuring that In preparing comments for the USTR,
begins at the grassroots. We often work we remain true to our fundamental many volunteer members, including those
with many interest groups inside and out- principles and implement policy and on the task force, committees, leaders,
side the ABA to achieve broad support regulatory positions on critical IP issues and oficers, had the beneit of review-
for our positions—which then enables is sometimes a lengthy but always care- ing a rich history of past Section policy to
us to speak with an inluential, power- ful and measured process. A couple of ensure consistency and develop content.
ful, and balanced voice. We frequently examples illustrate how this works. We spoke to the USTR about forced IP
collaborate with other ABA Sections, This past August, the United States transfers, compulsory licensing, bad faith
including Antitrust, International Law, Trade Representative (USTR) announced trademark registrations, piracy-enabling
Litigation, and Business Law. At times, its launch of an investigation under Sec- practices, and counterfeiting. As it turned
the process toward development of policy tion 301 of potential abuses of IP rights by out, the ABA-IPL Section was the only
may also require approval by all 500 or China titled “China’s Acts, Policies, and major IP law association that appeared.
so members of the ABA House of Del- Practices Related to Technology Trans- And because most American entities with
egates (HOD), which is a representative fer, Intellectual Property, and Innovation.”
body comprised of lawyers from virtually The USTR sought comments from the Continued on page 5
every type of practice and interest group public on a wide range of issues, such as Scott F. Partridge is chair of the ABA
in the United States. The HOD is respon- the forced transfer of technology (includ- Section of Intellectual Property Law. He is a
sible for approving ABA-wide policy at ing IP rights) in return for market access, partner at Baker Botts LLP in Houston,Texas.
its biannual meetings. compulsory licensing, piracy, and coun- He specializes in patent, trade secret, and
Of course, while we endeavor to terfeit goods, among other issues. Given licensing litigation and client counseling in all
reach a consensus position, it is rare that a very short turnaround time for com- areas of intellectual property law. He can be
we achieve unanimous agreement—not ments, the ABA-IPL Section immediately reached at scott.partridge@bakerbotts.com.
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
®
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
40 Patenting the Future of Medicine:
The Intersection of Patent Law and
Artiicial Intelligence in Medicine
Artiicial intelligence is transforming the world of medicine
and patent law must keep pace. This article examines
patentability, inventorship, and ownership issues surrounding
medical AI.
By Susan Y. Tull
Pg. 18 44 The APA in PTAB Proceedings: Notice
and an Opportunity to Be Heard
26 Strategic Predictions: Leveraging The authors provide lessons in holding the Patent Trial and
Appeal Board accountable under the Administrative Procedure
Art Unit Allowance Rates to Act according to recent precedent from the Federal Circuit.
Drive the Selection of Appeal By Daniel Zeilberger and Michael Wolfe
Decision Makers
Appeal-entry decisions are often burdensome. While a
signiicant portion of appellants quickly exit the appeal
cycle with positive results, most appellants remain in
48 Navigating through the
the cycle with large time and money investments. An Obviousness-Type Double
optimized strategy for navigating appeal-entry decisions Patenting Mineield
would greatly beneit applicants. The empirically
Obviousness-type double patenting (ODP) is a judge-made
supported strategies discussed in this article show that
doctrine intended to prevent a patentee from unfairly extending
data analytics in prosecution can make an easy solution
its patent term by obtaining different patents for essentially the
out of a large problem.
same invention. This article explores recent Federal Circuit
By Sameer Vadera and Kate S. Gaudry decisions regarding ODP and strategies to avoid ODP land
mines.
30 IP Attachés: Providing Services By Amelia Feulner Baur and Elizabeth A. Doherty
around the World to IP
Practitioners and Their Clients
The United States Patent and Trademark Ofice’s
54 Preserving Provisional Rights for
intellectual property (IP) attachés serve as a valuable Pre-Issuance Patent Damages
resource to legal practitioners and their clients through This article summarizes recent Federal Circuit interpretation
their advocacy with foreign governments, as well of 35 U.S.C. § 154(d) (“Provisional Rights”), identiies
as through providing information and counseling some open issues with the statute, and offers guidance to
domestically. practitioners on preserving this potentially valuable remedy.
By Dominic Keating By Brian V. Slater and John P. Dillon
Landslide® magazine To request reprints: www.americanbar.org/utility/ Requests for subscriptions or back issues:
(ISSN: 1942-7239) is published bimonthly in reprint.html. The price of an annual subscription 1-800-285-2221, orders@americanbar.org, or
January/February, March/April, May/June, July/ for members of ABA-IPL ($35.00) is included ABA Service Center, 321 N. Clark St., Chicago,
August, September/October, November/December in their dues and is not deductible therefrom. IL 60654-7598
as a service to its members by the American Bar The price of membership in the ABA Section of Editorial questions: 312-988-6089,
Association Section of Intellectual Property Law Intellectual Property Law is the price of ABA erin.remotigue@americanbar.org and
(ABA-IPL), 321 N. Clark St., Chicago, IL 60654- membership plus $105. ABA membership is a 312-988-6264, amy.mandel@americanbar.org
7598, tel. 312-988-6264. Periodicals postage is prerequisite for Section membership.
Postmaster: Send address changes to Landslide
paid at Chicago, Illinois, and additional mailing To become a member of the ABA and magazine Member Records, American Bar
ofices. Copyright ©2018 by the American Bar the Section or to change your address: 1-800- Association, ABA Service Center,
Association. All rights reserved. No part of 285-2221 or www.americanbar.org/groups/ 321 N. Clark St., Chicago, IL 60654-7598,
this publication may be reproduced, stored in a intellectual_property_law.html. Individuals service@americanbar.org
retrieval system, or transmitted in any form or by who are not ABA-IPL Section members and
any means, electronic, mechanical, photocopying, institutions not eligible for ABA membership may Advertising Sales:
recording, or otherwise, without the prior written subscribe to Landslide magazine for $195.00 per M.J. Mrvica Associates, Inc.
permission of the publisher. year, $250.00 per year for subscriptions addressed 2 West Tanton Ave
outside the United States and its possessions. Berlin, NJ 08009
Single copies are $50.00 plus $3.95 for postage ph: 856-768-9360 fx: 856-753-0064
and handling. Email: mjmrvica@mrvica.com
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
Perspective Continued from page 1
businesses in China avoided this investiga- our positions with a view toward support- membership standing alone is critical
tion entirely (presumably because of fear ing the long-term role of the IP system to maintaining our Section’s strong and
of retaliation), the submission of our views in strengthening the US economy, and inluential IP voice, we welcome the
was all the more important. generally avoided merely addressing active addition of your voice and hope
While the USTR process did not short-term interests. that you will join one or more of our
require HOD approval, the Section often Through our deliberate and diligent committees and subcommittees that are
presents resolutions to the HOD, which process and working in conjunction of particular interest to you. Thank you
then allows us to speak for the ABA as a with our ABA colleagues, the ABA-IPL for your membership and participation. n
whole rather than only as a Section. This Section continues to have a signiicant
is of key importance, for example, when impact on IP law. We communicate fre- Endnotes
we may want to ile an amicus curiae quently with top oficials at the USPTO 1. Letter from Scott F. Partridge, Chair,
brief in the US Supreme Court or the US on matters ranging from patent eligibil- ABA Section of Intellectual Prop. Law, to Hon.
Court of Appeals for the Federal Circuit. ity, changes to inter partes review (IPR) William L. Busis, Chair, Section 301 Comm.,
We recently sought and obtained HOD procedures, sharing services with the Ofice of the U.S. Trade Representative
approval to ile an amicus brief in the Department of Commerce, and amend- (Sept. 27, 2017), https://www.american-
NantKwest case, involving the USPTO’s ments to trademark and patent rules. The bar.org/content/dam/aba/administrative/
attempts to collect its attorneys’ fees— Section regularly submits comments to intellectual_property_law/advocacy/advocacy-
whether it wins or loses—in district court the US and international governments. 20171927-comments.authcheckdam.pdf.
reviews of USPTO decisions. Our Sec- For example, we met recently with the 2. Written Testimony of Scott F. Partridge
tion believes that the USPTO’s actions White House IP enforcement coordi- on Behalf of the ABA Section of Intellectual
raise a serious access to justice issue, nator on IP enforcement in the United Property Law Before the Section 301 Commit-
among others. We also sought HOD States and abroad, including China. tee in the Section 301 Investigation Concerning
approval to establish ABA policy over Your ABA-IPL Section is a respected, China’s Acts, Policies, and Practices Related to
the years on issues such as patent eligi- credible, and objective voice on all Technology Transfer, Intellectual Property, and
bility, independence of the US Copyright aspects of IP law. For those reasons, Innovation (Oct. 10, 2017), https://www.amer-
Ofice, and basic trademark law issues we will continue to have a seat at the icanbar.org/content/dam/aba/administrative/
such as those involved in the In re Tam table when important IP issues are up intellectual_property_law/advocacy/advocacy-
case. In all these examples, we developed for debate and resolution. While your testimony-20171010.authcheckdam.pdf.
Presents
To register: Call 1-800-285-2221 Turn to page 23 to read “Ten Years after KSR, Motivation to Combine
or visit www.americanbar.org/iplaw. Moves Back into the Spotlight” by Chao Gao and Peter M. Jay.
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
PROFILES IN IP LAW
An Interview with
Ronald D. Coleman,
Likelihood of Confusion® Blog
By Lindsay B. Allen
Ronald D. Coleman is a partner at Archer Law in New intertwined and built on each other, so that in a short time I
York City and Hackensack, New Jersey, practicing commer- was the “go-to guy” in certain pockets of the blogging world
cial litigation with a focus on trademark, copyright, and First for almost any legal issue faced by bloggers.
Amendment law. He also started the Likelihood of Confu- I was convinced that if people would ind their way to my
sion® blog in 2005 and continues to blog regularly about website, it would be a way for clients to ind out about me,
trademark, copyright, and free speech. Likelihood of Confu- which was, strange as it seems, not all that common for law-
sion is one of the most widely read intellectual property law yers in the relatively early days of the Internet.
blogs in the world. His recent successful argument before the
US Court of Appeals for the Federal Circuit, sitting en banc, What do you attribute to the success of your blog? How have
and subsequent appearance before the United States Supreme you been able to grow your readership?
Court on behalf of his client, Simon Tam of The Slants rock Through my law irm website, even before the blog began, I
band, resulted in the Supreme Court striking down a portion came to represent a company called S&L Vitamins that was get-
of the Lanham Act on free speech grounds. ting cease and desist letters from the companies that made the
Australian Gold and Designer Skin tanning lotions, and a num-
Mr. Tam and his Archer team are the 2018 Mark T. Banner ber of others. These companies ended up going after my client
Award honorees and will receive the award during ABA-IPL’s in a series of “unauthorized distribution” cases throughout the
33rd Annual Intellectual Property Law Conference in April. country premised on trademark infringement. My client threat-
ened these companies’ existing price level and distribution
How did you irst become interested in intellectual property law? mechanism, but what my client was doing was completely legal.
My mother was a legal secretary for the Cities Service Corpo- We ended up litigating more or less the same case against several
ration, which used to have a technical research center in central companies over the course of several years around the country.
New Jersey, near where we lived. I visited her from time to Several things happened to my practice during the course
time when I was in high school and encountered the old bound of this litigation: I had stepped up my trademark game; I was
volumes of the Trademark Oficial Gazette, which I found mes- able to get more experience doing irst seat trial work, which
merizing. That was my irst experience with trademark law. I really enjoyed; I was getting the opportunity to litigate all
over the country; and I was experimenting with sharing these
How did you get involved in blogging? experiences on my blog.
I was always someone who liked to read public interest/ A little bit later, after I had moved my practice to another
public policy-type magazines, but I never felt like I could get irm, one of the bloggers I represented, Bob Cox, ran what was
into the conversation, and I did feel like I had something to then a very popular blog called The National Debate. He had
say. I studied economics and political science in college and been writing for a while about how frustrated he was that the
had been very interested in issues and debate, and it frustrated New York Times never issued corrections of factual errors that
me that there were tremendous barriers, it seemed, to getting were contained in op-ed pieces. The Times’ view was that if it
into the conversation. Blogs had discussion forums and com- was news, they would make a correction, but if it was an op-ed,
ments, and you could earn your way into the conversation on they would not. Bob argued that there were very substantial
the merits, which I did. errors on the op-ed pages as a result, and the pages themselves
Soon I developed relationships with some of the bloggers were extremely inluential and it was objectionable in his view.
where I was advertising, and one of them encouraged me to He put together a parody of the corrections page as he would
start my own blog a little bit after I started the Coleman Law imagine it would look like if the New York Times made op-ed
Firm. At this point, I had also gotten involved with work- corrections, and posted the parody on his website.
ing on behalf of bloggers, usually on a pro bono basis, on Next thing he knew, he received a DMCA takedown order
free speech issues. These two paths became more and more for this parody, and he ended up inding me based on my
prior work for other bloggers on a pro bono basis. In return
Lindsay B. Allen practices trademark, copyright, and unfair for my representation, he posted links to my blog to tell his
competition law at Perkins Coie LLP. She can be reached at readers that I was helping him, which raised my online proile
LAllen@perkinscoie.com. tremendously. We did get the Times to retract its takedown
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
notice, which started to generate a lot more interest in what I As I mentioned before, before starting my own irm I had
was doing. Blogging became something that was very funda- been at a irm called Pitney Hardin, which is now part of Day
mental to my professional identity after that representation. Pitney, where I represented a young man named Steven Brod-
sky in a fairly high-proile case against a missionary group called
You were among the irst group of lawyers to start blogging about Jews for Jesus. That case came my way because of my blogging.
intellectual property. How were you able to ind your voice? Many observers shared my view that in the Brodsky litigation,
When I initially started the blog, I thought that because there which was iled before the anticybersquatting provisions were
was already a blog on trademark law—Marty Schwimmer’s added to the Lanham Act, trademark claims were employed to
Trademark Blog—what is the sense in doing another one? That’s restrict free expression on a controversial topic, namely Brod-
how small the world looked at the time. I had met Marty at the sky’s opposition to the group. That case was the irst one to sort
end of 2000, when I was on a panel for INTA’s Trademarks in of put me on the map in trademark litigation, though the out-
Cyberspace program, arising out of my work on Jews for Jesus come was disappointing. Later, when I got involved with the
v. Brodsky, an early domain name trademark case. I came to real- S&L tanning lotion cases as well as claims against review sites
ize, though, that we had different perspectives, and I could write and online directories and cases involving network advertis-
from my own perspective. Marty encouraged me and gave me ing, I came to see this pattern continue—“unauthorized use of a
some important links, which was of great value in terms of my trademark” was becoming a way to shut down communication,
credibility. It turned out to be a very good investment. commercial or otherwise, on the Internet, even where there was
no meaningful proof of a likelihood of confusion.
Do you have any advice for lawyers who would like to get That theme—the use of trademark claims as a form of anti-
into blogging today? competitive conduct—came to a head when I spent several years
It’s not for everyone, frankly. Because I’m also fundamen- representing a gripe site called PissedConsumer.com in a series of
tally a writer—I wrote for a student lawyer magazine while I was cases where people tried to sue them for unauthorized trademark
in law school—and I’ve just always been a writer, it was a very use in reviews or in URLs generated by consumers and where,
good match for me and a great way for me to develop my prac- again, the fundamental requirement of an infringement claim—a
tice and have fun, too. But if you’re intellectually curious and you likelihood of confusion—was consistently absent, but the lawsuits
have something to say, even if you’re just starting your career were used as anticompetitive tools. We got very good results on
and not necessarily billing time every minute of the day the way their behalf, and I became more and more attuned to this phenom-
you would like to be, why not take your creative inclinations and enon of the misuse of trademark law on the Internet.
thinking or the stuff you’ve put into briefs, or perhaps the lines of What I found really gratifying was that as time went on,
inquiry that end up on the cutting-room loor, and turn them into judges became much savvier about how trademark law was
blog posts? Through your posts, you can keep generating interest being abused in this way than they had been previously, and
and SEO (search engine optimization) and a reputation. that I could say I had some small part in that. Ultimately the
First Amendment work we did for the Slants brought that
Your representation of bloggers was one way you got into the process full circle and made me feel some small personal vin-
practice of Internet law. How did you get involved with First dication, though the issues were not closely related, for the
Amendment law? outcome in the Brodsky case almost 20 years earlier. n
®
visit Landslide magazine online
• additional features • additional content • more “Decisions in brief”
www.americanbar.org/publications/landslide
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
Image: iStockPhoto
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
RIP
J
ust last night at a poker game: “I should have
drank this beer earlier.”
Just last night from the Washington Nation-
als’ broadcast booth: “He could have went to
second base.”
And from the lyrics of “Out the Door” by Stick Fig-
ure: “I could have saw it coming from far and away.”
The past participle is dying a slow death. Why?
Because many people have forgotten—or never
learned—the “principal parts” of verbs. Unfortunately,
most people did not have my middle school English
teacher—Miss Hamrick. For she drilled the principal
parts into our numb little skulls way back in the 1950s.
I can remember Miss Hamrick’s chant to this day:
Past
tenses correctly. We would thus say: “I should have
drunk this beer,” “He could have gone to second base,”
and “I could have seen it coming.”
Participles
According to some grammarians, verbs have three
principal parts (go, went, gone). Others point out that
verbs have ive: I go, she goes, she went, she has gone,
she is going. From the ive principal parts of a verb, we
can conjugate a verb in all possible tenses.
So let’s name the ive principal parts for the verb walk:
1. Ininitive or irst-person present tense: to walk, I
walk.
2. Past tense: I walked, she walked, we walked.
3. Past participle: I have walked, she has walked,
they have walked.
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
For the verb walk, we can form all possible tenses with the Passive Voice
(1) ininitive or irst-person present tense (walk), (2) past tense The past participle also enables us to form the passive voice.
(walked), (3) past participle (walked), (4) third-person singular We simply take some form of the verb to be and, again, add
present tense (walks), and (5) present participle (walking). the past participle. Thus we can write in the present tense:
Notice that the past tense and the past participle of walk are “This case is decided by a trial court.” Or in the past tense:
the same word: walked. Most verbs in the English language “This case was decided by a trial court.” Or in the future
form their past tense and their past participle simply by adding tense: “This case will be decided by a trial court.”
the sufix – ed. We call these “regular verbs,” because they all
follow the same rule for forming both their past tense and their Past-Participial Adjectives
past participle: just add – ed. Other regular verbs, we should The past participle of a verb can serve as an adjective. Thus
note, might use different endings, but they’re still “regular” we can refer to “the torn pocket,” “The Lost Colony,” or per-
because they follow the same rule for forming their past tense haps “the conjugated verb.”
and their past participle, e.g., feel, felt, felt; build, built, built.
Flubs
Irregular Verbs Grammatical disasters most often occur with the perfect
But then come the troublemakers: An irregular verb does not tenses: “He could have went to second base,” and on and on
follow a set of rules for forming its past tense and its past and on. The speaker—or writer—uses the past tense of an
participle. These verbs, alas, require the most dreaded of all irregular verb (went) to form a perfect tense: could have went.
academic tasks: memorization. He should, of course, have used the past participle and said:
Hence Miss Hamrick’s chant: drink, drank, drunk; go, “He could have gone to second base.”
went, gone; see, saw, seen. We had to memorize the irst-per-
son present tense or ininitive (go), the past tense (went), and Parents, Listen to Your Four-Year-Olds
the past participle (gone). In no other way, for irregular verbs, Small children treat all verbs as regular verbs. To form the
could we possibly determine the correct form of the perfect past tense, they just add – ed. (Smart little tikes!) So we hear:
tenses, that is, through the use of the correct past participle. “I builded it.” “I seed the movie.” “I drinked the juice box.”
Instead, we had to memorize that sucker. As gentle parents, we simply respond, “Oh, you built it?”
Notice that irregular verbs use one word for the past tense “You saw the movie?” “You drank the juice box?” In
(went) and a completely different word for the past participle an incredibly short period of time, they catch on. We
(gone). Please note, however, that some irregular verbs use the should, of course, do the same when the child mistakenly
same word for all three main principal parts: cast, cast, cast; uses the past tense—not the correct past participle—to form
burst, burst, burst; hit, hit, hit. Thus, today I hit the ball; yes- a perfect tense: “I have drank the milk.” “Oh, you have drunk
terday I hit the ball; and, as a completed fact, I have hit the ball. the milk?”
C. Edward Good provides on-site training programs in effective legal writing for corporations, government agencies, professional
associations, and law irms. Contact him at 240-GRAMMAR (cell) or cedwardgood@gmail.com.Visit his website at EdGood.com.
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
Irregular Verbs: The Three Main Principal Parts
Ininitive or Ininitive or
Past Participle: Past Participle:
First-Person Past Tense: First-Person Past Tense:
“I have . . .” or “I have . . .” or
Present Tense: “Yesterday, I . . .” Present Tense: “Yesterday, I . . .”
“I could have . . .” “I could have . . .”
“Today, I . . .” “Today, I . . .”
arise arose arisen lie (to recline) lay lain
awaken awakened awakened lead led led
wake woke woken lend lent lent
waken wakened wakened light lit lit
beat beat beaten ride rode ridden
become became become ring rang rung
begin began begun rise rose risen
bend bent bent see saw seen
bet bet bet shine shone shone
bite bit bitten shrunk or
shrink shrank or shrunk
shrunken
bleed bled bled
sing sang sung
blow blew blown
sneak (regular) sneaked sneaked
break broke broken
snuck (OK in
bring brought brought sneak (irregular) snuck
America)
burst burst burst speak spoke spoken
cast cast cast speed sped sped
come came come spend spent spent
dive (regular) dived dived spring sprang sprung
dove (OK in
dive (irregular) dived steal stole stolen
America)
sting stung stung
do did done
stride strode stridden
drink drank drunk
string strung strung
drive drove driven
swear swore sworn
fall fell fallen
sweat sweat sweat
forget forgot forgotten
swim swam swum
forgive forgave forgiven
take took taken
freeze froze frozen
tear tore torn
get got gotten or got
throw threw thrown
give gave given
thrust thrust thrust
go went gone
wear wore worn
hang (a picture) hung hung
weave wove woven
hang (a criminal) hanged hanged
wind wound wound
lay (to place
laid laid
something) write wrote written
I
s the natural result of a known process considered inherently obvious? Patent practitio-
ners might quickly jump to the conclusion that any natural result of an arguably known
and/or obvious process is itself inherently obvious and unpatentable. The Federal Cir-
cuit’s ruling in Millennium Pharmaceuticals, Inc. v. Sandoz this past summer, however,
demonstrates this is not always the case.1
Indeed, the Federal Circuit in Millennium sent an important message that the existence
of inherent disclosures may not necessarily be enough to render a patent claim obvious.
The claimed invention in Millennium concerned a chemical compound known as bortezo-
mib. Bortezomib is used in the treatment of patients with multiple myeloma and mantle cell
lymphoma who have received at least one prior therapy, and Millennium Pharmaceuticals
markets it under the brand name Velcade.2 Although bortezomib was known and described in
a prior art patent, it had not achieved FDA approval by the time the patent-in-suit was applied
for.3 It was previously known that bortezomib suffered from instability, rapid degradation in
liquid formulations, and insolubility. After many failed attempts to develop a viable liquid for-
mulation that resolved the issues in bortezomib, the patent applicants developed a promising
formulation. This formulation was prepared by lyophilization (freeze-drying) using a known
bulking agent, mannitol.4 The formulation was the subject of U.S. Patent No. 6,713,446 (’446
patent) and ultimately became the formulation for Velcade.
Three generic drug manufacturers iled abbreviated new drug applications seeking approval
for a generic version of Velcade. In response, Millennium iled suit in the District of Delaware. At
trial, the closest and sole prior art was found to be an earlier patent iled by Millennium’s predeces-
sor claiming the bortezomib compound, and both parties agreed that bortezomib was the proper
lead compound for the obviousness analysis.5 Both parties also agreed that the Velcade compound
provided unexpected properties that solved the problems of bortezomib.6 The generic defendants
argued that lyophilization would have been an obvious process to stabilize bortezomib. Specii-
cally, the generic defendants argued it was a “standard” formulation method that a formulator
would have considered.7 They further argued that there were “only ‘half a dozen or so’ . . . ‘phar-
maceutically acceptable bulking agents’” with the “most prominent” being mannitol, and thus
it would have been obvious to lyophilize bortezomib with mannitol.8 According to the generic
defendants, if the court inds freeze-drying with mannitol to be obvious, then the patent is nec-
essarily invalid because the claimed formulation “is the inherent result of that combination.”9 To
further support their position, the generic defendants argued that Millennium had also admitted to
Jennifer T. Nguyen is an associate at Paul Hastings, LLP in New York, New York. She is a member
of the intellectual property practice and focuses her practice on complex patent litigation. She can
be reached at jennifernguyen@paulhastings.com. Preston K. Ratliff II is a partner and chair of the
litigation practice at Paul Hastings LLP in New York, New York. He focuses his practice on complex,
Image: iStockPhoto
T
he America Invents Act (AIA) created new US post-grant USTPO conducts IPRs balances this imperative with the goal
patent challenge proceedings—including inter partes of having a strong patent system. Patents have been and are
review (IPR). Conducted in the United States Patent and routinely invalidated in IPRs, leading some commentators to
Trademark Ofice (USPTO), post-grant challenges are adjudicated describe the PTAB panels as patent “death squads.”6 Many
by administrative patent judges (APJs) of the Patent Trial and patent owners, if given the choice, would prefer to insulate
Appeal Board (PTAB). Post-grant challenges have proved popu- their patents from USPTO IPR proceedings.
lar with patent challengers because: they are faster and cheaper
than traditional district court litigation;1 the standard to invalidate a Eleventh Amendment Sovereign Immunity
patent is lower than that employed by district courts;2 claim inter- Recently, several PTAB panels determined that state entities,
pretation is broader—potentially opening up claims to a wider such as public universities that are arms of a state, enjoy sov-
prior art pool;3 the ability to amend claims is practically nonexis- ereign immunity to IPRs under the Eleventh Amendment of
tent;4 and APJs are perceived as being more technologically savvy the US Constitution.7 This is an important development for at
than judges and juries sitting in federal district courts.5 least the following reasons.
Patent quality is a perennial topic for the USPTO and the First, public universities hold signiicant amounts of valu-
patent bar. Some stakeholders do not believe the way the able intellectual property since the Bayh-Dole Act, which
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
allows patenting and licensing of inventions made with fed- immunity applies to the University of Maryland as a state
eral funds.8 And, in the face of declining federal funding,9 entity and thus dismissed it from the IPR proceeding.17 The key
universities can create viable alternative revenue streams by question, however, was whether to terminate the IPR against
licensing their intellectual property (e.g., patents and patent the remaining non-state entity party, an exclusive licensee.
applications) to start-up companies. In NeoChord, Inc. v. University of Maryland, Baltimore,
Second, the Eleventh Amendment,10 as interpreted by pan- the PTAB noted that the university retained certain rights
els of the PTAB, de facto creates two groups of patents: one under the licensing agreement, such as the right to sue a third
protected from IPR challenges and one that is unprotected. party for infringement if the licensee fails to do so, and there-
All other things being equal, a protected patent is more valu- fore transferred less than “substantially all” rights to the
able than an unprotected patent. licensee. Accordingly, the panel concluded that the university
remained a “necessary and indispensable party” and thus ter-
Sovereign Immunity as Applied to the State Entity: minated the proceeding.18 Under NeoChord, the dismissal of
Covidien the state entity licensor can practically extend sovereign pro-
In January 2017, the PTAB dismissed a trio of IPRs based on the tection to the non-state licensee, as discussed in detail below.
University of Florida’s claim of sovereign immunity in Covidien
LP v. University of Florida Research Foundation Inc.11 Covidien Non-State Co-Owner: Reactive Surfaces
had iled three IPRs against patents owned by the University of In Reactive Surfaces Ltd., LLP v. Toyota Motor Corp., the
Florida, and the PTAB concluded that state sovereign immunity PTAB maintained an IPR even after dismissing the Regents
applies to IPR proceedings and thus terminated them.12 of the University of Minnesota on sovereign immunity
First, the PTAB cited the Supreme Court decision Federal grounds.19 The panel stressed that, unlike the licensor-licensee
Maritime Commission v. South Carolina State Ports Author- relationship in NeoChord, the absent sovereign party and the
ity and held that a state’s sovereign immunity could bar remaining nonsovereign party are co-owners holding identical
certain administrative agencies from adjudicating a private interests in the patent.20 It thus concluded that the IPR may
party’s complaint against a nonconsenting state.13 The PTAB continue because the remaining party would adequately rep-
Vern Norviel is a partner at Wilson Sonsini Goodrich & Rosati PC in San Francisco, California. He specializes in IP/life sciences patent
counseling. Vern can be reached at vnorviel@wsgr.com. Charles Andres is an associate at Wilson Sonsini Goodrich & Rosati in Washington,
DC. He specializes in IP counseling and FDA/life sciences practices. He can be reached at candres@wsgr.com. Xiaozhen “Shawn” Yu is an
associate at Wilson Sonsini Goodrich & Rosati in Washington, DC. He specializes in IP/life sciences patent counseling. He can be reached at
syu@wsgr.com. The opinions expressed are those of the authors and do not necessarily relect the views of the irm or its clients. This article is
intended solely for general information purposes and should not be taken as legal advice.
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
Amendment may be precisely what the Supreme Court distinction between NeoChord and Reactive Surfaces, licensing
envisioned. agreements could become preferred to joint research agree-
ments—provided the license is appropriately crafted and fully
Waive Sovereign Immunity in the USPTO by Filing accounts for patent statutory provisions and considerations.
Patent Infringement Suit? Second, licensing fees and running royalties paid to sover-
Where sovereign immunity is present, a prospective pat- eign entities may result in product price increases that could
ent challenger might consider waiting until the state entity be passed on to consumers.
iles a patent infringement suit in a federal court, potentially Third, Congressional and USPTO oversight of the PTAB
waiving sovereign immunity. Indeed, the Covidien panel may become more hands-on, as some have opined that any
expressly declined to decide “whether the existence of such unintended consequences of PTAB sovereign immunity deci-
a case would effect a waiver of sovereign immunity.”23 How- sions might lie not with the PTAB, but with its oversight.33
ever, in this regard, the Federal Circuit has shown reluctance Finally, district court litigation would take on an increas-
to extend waiver of sovereign immunity from one suit to a ing importance in adjudicating patent proceedings—perhaps
separate suit, let alone one in a completely different forum.24 with an emphasis on refereeing noninfringement arguments.
Accordingly, it is possible that sovereign immunity at the
PTAB would remain intact even if a state entity iled an Conclusion
infringement suit in a federal court. Many questions remain as authority on state and tribal sover-
eign immunity evolves. And the issues raised by state and tribal
Tribal Sovereign Immunity: Allergan IPR sovereign immunity might be an opportunity for a reset. For
The question of the metes and bounds of sovereign immunity, example, the USPTO might wish to consider (1) increasing
in this case tribal sovereign immunity, is currently being tested director oversight of the PTAB, and (2) implementing the routine
by a global pharmaceutical company, Allergan, which owns ability to amend claims during IPRs, as in European oppositions.
six Orange Book–listed patents relating to the blockbuster In any event, these cases surely will not be the inal word
drug Restasis. Competitors, looking to remove these barriers on sovereign immunity for patent holders, as they argu-
to entry, iled IPR challenges against all six patents.25 Aim- ably abrogate congressional intent expressed in the AIA. Of
ing to protect its patents, Allergan transferred ownership of the course, sovereign immunity from IPRs would be moot if the
patents to the Saint Regis Mohawk Tribe.26 In turn, the Tribe Supreme Court holds that IPRs are not constitutional.34 But
granted Allergan exclusive licenses.27 Under the agreement, the one thing is certain: interested parties should keep abreast
Tribe will receive $13.75 million and will be eligible to receive of the latest developments, regularly consult counsel, and be
$15 million in annual royalties.28 As the owner of the patents, prepared to take appropriate legal action. n
the Tribe announced plans to rely on the Covidien and Neo-
Chord decisions in motions to dismiss the IPRs.29 Endnotes
Allergan is not alone. SRC Labs LLC, for example, has also 1. Am. Intellectual Prop. Law Ass’n (AIPLA), 2015 Report
transferred patent rights to the Tribe.30 Still, it is not clear whether of the Economic Survey 37, 43 (2015).
tribal sovereign immunity will ultimately provide the same protec- 2. See 35 U.S.C. §§ 282(a), 316(e).
tion as state sovereign immunity, as the Supreme Court has held 3. Cuozzo Speed Techs., LLC v. Lee, 136 S. Ct. 2131, 2134 (2016).
that state sovereign immunity is rooted in the Constitution, while 4. Patent Trial and Appeal Board Motion to Amend Study,
tribal sovereign immunity is a creation of federal law.31 USPTO (Apr. 30, 2016), https://www.uspto.gov/sites/default/iles/
Patent owners are closely watching developments in this documents/2016-04-30%20PTAB%20MTA%20study.pdf.
area.32 If Allergan’s approach succeeds, some may argue 5. Jennifer R. Bush, Administrative Patent Judges: Not Your Typi-
that the failure to counsel a client with valuable intellectual cal Federal Judge, Fenwick & West LLP (July 10, 2014), https://
property to implement this or a similar approach could even www.fenwick.com/publications/pages/administrative-patent-judges-
constitute malpractice. This may be especially true if courts not-your-typical-federal-judge.aspx.
determine that tribal immunity prohibits attacking patents in 6. Rob Sterne & Gene Quinn, PTAB Death Squads: Are All Commer-
district court on invalidity and inequitable conduct grounds, cially Viable Patents Invalid?, IPWatchdog (Mar. 24, 2014),
leaving noninfringement as the sole dispute at issue. http://www.ipwatchdog.com/2014/03/24/ptab-death-squads-are-all-
commercially-viable-patents-invalid/id=48642/.
Practical Implications for PTAB Practice 7. Sovereign Immunity: A Post-Grant Tool for Patent Owners?,
First, many patent owners will likely make deals to insulate their PTAB Rev. (Wilson Sonsini Goodrich & Rosati, Palo Alto, Cal.),
patents against IPRs. Sovereign entities, such as public univer- June 2017, at 4, https://www.wsgr.com/email/PTAB-Review/2017/
sities, Indian tribes, or entities owned by a foreign country, may June/PTAB-Review-June-2017.pdf.
also approach patent owners to propose similar arrangements. 8. 35 U.S.C. §§ 200–212.
Lawyers will also increasingly counsel their patent owning cli- 9. Ronda Britt, Universities Report Continuing Decline in Fed-
ents to consider entering into these arrangements. eral R&D Funding in FY 2014, Nat’l Sci. Found. (Nov. 17, 2015),
In particular, transaction counsel will look to include, in https://www.nsf.gov/statistics/2016/nsf16302/.
licenses to university and tribal patents, provisions speciically 10. U.S. Const. amend. XI (“The Judicial power of the United
enumerating that there is no waiver, or only limited waiver under States shall not be construed to extend to any suit in law or equity,
certain conditions, of sovereign immunity. In fact, based on the Continued on page 62
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
To Create and Own a
Nontraditional Trademark,
Just Follow Tradition
By Robert D. Litowitz and Linda K. McLeod
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
Image: iStockPhoto
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
The courts and commentators have relied on the term Another River to Cross—Functionality
“device” to boldly take trademarks places they traditionally have Functional Functionality
not gone before. This article will focus on areas of these non- Besides secondary meaning, another hurdle for protecting
traditional marks that have pushed the trademark frontier past colors and many other nontraditional trademark formats is the
the traditional boundary of words, names, and symbols. These requirement that such marks be nonfunctional.
are colors, scents, lavors, textures, motions, holograms, and A mark is functional if it is “essential to the use or pur-
interiors. (Sound marks, another nontraditional category, were pose of the [product] or if it affects the cost or quality of the
addressed in a previous issue of Landslide; product shapes and [product].”10 Color marks may be functional, for example,
trade dress, while often included in the nontraditional category, when the color results as a natural consequence of the manu-
have been well-accepted trademark formats for decades.) facturing process. In one case, the Federal Circuit held that
the color black for marine outboard motors is functional
Color My World Trademarks because it makes the motor look smaller and coordinates
Color marks consist of one or more colors used on a particu- well with other colors.11 In another decision involving a now-
lar product or in connection with a service. For marks used in archaic product, the United States Patent and Trademark
connection with goods, color may be used on the entire sur- Ofice (USPTO) held the combination of yellow and orange
face of the goods, on a portion of the goods, or on all or part functional for public telephones because those colors made
of the packaging for the goods. For example, in Qualitex, the the pay phones easier to see in the dark.12 Other cases where
Supreme Court held that green-gold used on dry cleaning color was found functional include the color purple for sand-
press pads was a protectable trademark where the color had paper,13 the color pink for surgical wound dressings,14 and the
been used and advertised so extensively that it had transcended color coral for earplugs.15
its primary role (just a color) and had acquired a “secondary On the other hand, color was found nonfunctional, and trade-
meaning,” namely, it became a source indicator—a trademark.3 mark-worthy, in cases involving the color yellow for caulking
Previously, in In re Owens-Corning Fiberglas Corp., the Fed- guns16 and the color orange for a snow removal hand tool.17
eral Circuit found the color pink as applied to ibrous glass
residential insulation registrable where the evidence showed Aesthetic Functionality
the color had acquired secondary meaning.4 Similarly, “service When color is used to make a fashion statement, a corollary to
marks may consist of color used on all or part of materials used the functionality doctrine, called “aesthetic functionality,” may
in the advertising and rendering of the services.”5 come into play. Aesthetic functionality focuses on whether a
Color marks cannot be registered on the Principal Reg- product feature, such as color, makes the entire product more
ister or enforced against an infringer without a showing of desirable because of how it looks, not how it works or per-
acquired distinctiveness under § 2(f) of the Trademark Act, forms. The Supreme Court in the Qualitex case recognized that
15 U.S.C. § 1052(f).6 color can sometimes drive consumer appeal, although in that
Not all uses of color qualify for trademark protection. For case, it found that the murky green color of dry cleaning press
example, the Federal Circuit afirmed, per curiam, the Trade- pads did not have such commercial allure. But by recognizing
mark Trial and Appeal Board’s (TTAB’s) refusal of registration the possibility of aesthetic functionality, the Court in Qualitex
for the “blue motif” of Hudson News retail stores.7 The TTAB gave the somewhat moribund doctrine new vitality.
had concluded that customers likely would perceive the store’s Recently, aesthetic functionality had its moment in the
blue color as “nothing more than interior decoration” that spotlight when two high-fashion footwear icons battled over
“could be found in any number of retail establishments.”8 In the color red. Christian Louboutin had a US registration for
other words, no secondary meaning, no trademark. the color red for its signature red-lacquered soled women’s
However, a color can achieve trademark status when com- shoes. Louboutin saw red—and sued—when the legend-
panies promote it—and customers perceive it—as a source ary Yves Saint Laurent (YSL) fashion house launched a
indicator. One example is AstraZeneca’s use of purple for its line of totally red shoes that marched in Louboutin’s foot-
Prilosec and Nexium acid relux medications. AstraZeneca steps by also featuring red soles. The trial court, siding with
spent many millions of dollars over many years promoting its Louboutin, found the red sole “instantly” recognizable and
purple colored prescription and over-the-counter medications synonymous with Louboutin.18 But the trial court’s ultimate
as “The Purple Pills.” As a result, AstraZeneca not only was ruling favored YSL on aesthetic functionality grounds.19 More
able to obtain registrations for the color purple, but also was speciically, the trial court ruled that the Lanham Act did not
able to enjoin competitors for using purple on their generic “extend[] protection to a trademark composed of a single
versions of AstraZeneca’s blockbuster medications.9 color used as an expressive and deining quality of an article
of wear produced in the fashion industry.”20
Robert D. Litowitz is a partner at Kelly IP, LLP in Washington, Louboutin appealed to the Second Circuit Court of
DC. He specializes in trademark, copyright, and false advertising Appeals, which reversed.21 The appellate court concluded that
law, and can be reached at rob.litowitz@kelly-ip.com. Linda K. the trial court’s ruling conlicted with the Supreme Court’s
McLeod is a partner with Kelly IP, LLP. She specializes in trademark endorsement of single-color marks in Qualitex, concluding
prosecution, litigation, and counseling. She may be reached at “no special legal rule prevents color alone from serving as
linda.mcleod@kelly-ip.com. The authors thank Danielle Johnson, a trademark,”22 whether the color is applied to dry cleaning
associate at Kelly IP, LLP, for her contributions to this article. press pads or an elegant article of high fashion.
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
The Second Circuit explained that a mark is “aesthetically the Clarke case may suggest, the amount of evidence required
functional,” and therefore cannot enjoy trademark protection, to establish that a scent or fragrance functions as a mark is sub-
if (1) the design feature is essential to the use or purpose of the stantial.32 In In re Pohl-Boskamp GmbH & Co., the TTAB found
article, (2) the design feature affects the cost or quality of the that a peppermint scent mark for “pharmaceutical formulations
article, and (3) protecting the design feature would signiicantly of nitroglycerin” failed to function as a mark.33 Unlike Clarke,
undermine a competitor’s ability to compete.23 The court also where using any fragrance was unique within the embroidery
signaled that where aesthetic functionality is concerned, courts industry, pharmaceuticals often feature scents, with pepper-
should not jump to conclusions “merely because [a decorative mint being particularly common. The TTAB accordingly found
color or other fashion element] denotes the product’s desirable that such scents are more likely to be perceived as attributes of
source.”24 In short, that which glitters may still be a trademark. ingestible products than as indicators of source.34
Louboutin kept its trademark, but YSL still got its reprieve. The
Second Circuit found that YSL’s use of red from top to bottom Flavor—Hard to Swallow as Trademarks
did not infringe Louboutin’s red sole trademark. Flavor marks have not fared well compared to their cousins,
fragrance marks. In In re N.V. Organon, the TTAB in 2006
Scents and TM Sensibility: Fragrance Delecti? refused registration of a mark described as consisting of the
Once upon a time, scents and aromas likely would not be lavor orange used for a fast-dissolving pharmaceutical tab-
high on the list of “devices” one thought about when pon- let.35 In afirming the examining attorney’s refusal to treat this
dering trademark-eligible subject matter. But in 1990, the taste as a trademark, the TTAB found it “dificult to fathom
USPTO registered the following mark: “high impact, fresh exactly how a lavor could function as a source indicator in
loral fragrance reminiscent of Plumeria blossoms” for “sew- the classic sense, unlike the situation with other nontradi-
ing thread and embroidery yarn.”25 The examining attorney tional trademarks such as color, sound and smell, to which
conceded that “there is no inherent bar to registrability of an consumers may be exposed prior to purchase.”36 And lavor,
arbitrary, nonfunctional scent or fragrance.”26 But the exam- as well as scent, was in play in the Pohl-Boskamp case dis-
ining attorney concluded that the mark was “functional,” cussed above. As with the scent aspect of that putative mark,
framing the issue in terms of whether consumers could ever the peppermint lavor was found too ubiquitous to register.37
view—or more aptly, smell—a fragrance as a trademark, and Even if it had been unique, however, its inherent functional-
noting that many products, such as cosmetics and cleans- ity—making the medicine go down—would likely have been
ers, include fragrances to make them pleasant or attractive to an insurmountable obstacle to registration.
use.27 In rejecting the application, the examining attorney rea-
soned that consumers were unlikely to regard the applicant’s Reach Out and Touch Something
plumeria scent as indicating the source of the applicant’s Touch or tactile marks appear to be something like the uni-
threads and yarns, even though they were the only such corn of nontraditional marks. For reasons not entirely clear,
scented products on the sewing and embroidery market.28 the USPTO accepted for registration as inherently distinc-
Clarke, the applicant, countered with substantial evi- tive (meaning no secondary meaning evidence was required)
dence, via a declaration, which overcame the examining a mark consisting of a velvet textured covering on the sur-
attorney’s concerns and established that the plumeria scent face of a bottle of wine.38 The Supreme Court’s decision in
had achieved secondary meaning. Clarke’s declaration stated Wal-Mart Stores, Inc. v. Samara Brothers, holding that prod-
that hers was the irst and only scented thread and yarn, that uct design marks can never be inherently distinctive,39 might
she had heavily promoted her company as the sole source logically apply to tactile marks. But the USPTO thought
of sweet-scented embroidery products, and that customers otherwise, at least in this case. Other tactile marks include
associated the popular fragrance with Clarke’s products.29 To bottles with parallel lines of raised bumps for soft drinks,40
sidestep any argument that granting a fragrance trademark personal fragrance dispensers with a “pebble-grain” tex-
might hinder competition, Clarke preemptively declared that ture and “rubberized ‘soft-touch’ feel” for fragrances,41 and a
“[o]thers are free to adopt any other scent for their yarns and leather texture wrapping for wine.42
threads, including [other] loral scents.”30 With that narrow-
ing statement, and in view of Clarke’s uncontested statement I’d Like to Know Where You Got the Notion:
of acquired distinctiveness, the TTAB allowed Clarke’s fra- Motion Marks
grance mark to register.31 Trademarks can be iconic, they can be famous, and they can
Since Clarke’s plumeria-scented thread registration, the even inspire intense loyalty. But seldom are they moving
USPTO has granted registrations for the following goods and experiences, except that is when a trademark is a symbol or
services: images in motion. These so-called “motion marks” encom-
• Registration No. 2,463,044 (June 26, 2001) for “a pass a range of movements, animated, mechanical, and even
cherry scent” for synthetic lubricants; and human. Here are some examples:
• Registration No. 4,754,435 (June 16, 2015) for “the • Registration No. 1,928,423 (Oct. 17, 1995) for a com-
scent of bubble gum” for shoes, sandals, lip-lops, and puter-generated sequence showing the 20th Century
lip-lop bags. Fox logo from several angles as though a camera is
Still, relatively few “fragrance” marks make it to the Princi- moving around the structure;
pal and Supplemental Registers. That is because, despite what • Registration No. 2,092,415 (Sept. 2, 1997) for a
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
moving image design mark, comprised of an approxi- Walk Right in, Sit Right Down: Trademark
mately ive-second visual sequence depicting a city Protection for Restaurant and Retail Interiors
skyline, sky, and water enclosed in two concentric cir- In 1992, the Supreme Court afirmed a judgment of infringe-
cles containing the words “BROADWAY VIDEO,” with ment of trade dress in the appearance and decor of a chain
the words rotating clockwise as the city skyline comes of Taco Cabana Mexican-style restaurants in Texas.50 Since
into view, and concluding with a red lightning bolt then, the USPTO has issued numerous registrations on the
entering the circle and forming a “V”;43 Principal Register for restaurant and retail interior designs
• Registration No. 2,793,439 (Dec. 16, 2003) for a mark where applicants have established secondary meaning in their
consisting of the unique motion in which the doors of decors. These include:
a Lamborghini move parallel to the body of the vehicle • Registration No. 3,306,514 (Oct. 9, 2007) for a three-
but are gradually raised above the vehicle to a parallel dimensional loor display unit issued to Home Depot;
position; and • Registration No. 3,105,875 (June 20, 2006) for the
• Registration No. 3,182,163 (Dec. 12, 2006) for a telecom- appearance and design of a restaurant “evoking a neo-
munications services mark consisting of a person whose industrial feel” issued to Chipotle Mexican Grill; and
hands are in motion coming together to form the letter “T”: • Registration No. 4,839,216 (Oct. 27, 2015) for the inte-
one hand forms the vertical part of the letter “T,” while the rior design of the In-N-Out Burgers restaurants.
other hand forms the horizontal part of the letter “T.”44 The USPTO has also registered many other marks consisting
of restaurant or retail interior decor on the Supplemental Reg-
There’s More to the Picture Than Meets the Eye: ister, meaning the USPTO has deemed the marks potentially
Hologram Marks eligible for registration pending proof of secondary meaning.
According to the Trademark Manual of Examining Proce-
dure (TMEP), “[a] hologram used in varying forms does not And In the End, the Mark We Take Is Equal to the
function as a mark in the absence of evidence that consum- Mark We Make
ers would perceive it as a trademark.”45 In In re Upper Deck Trademark law embraces far more than names, words, and
Co., the TTAB held that a hologram used on trading cards in logos. But, to paraphrase Ringo Starr, obtaining rights in a
varying forms did not function as a mark, because the record nontraditional mark “don’t come easy”—it typically requires
showed that other companies used holograms on trading extensive sales over time and considerable advertising tar-
cards and other products for nontrademark purposes (e.g., as geted toward elevating the nontraditional mark to trademark
anticounterfeiting devices), and there was no evidence that status. Once secondary meaning has been achieved, compa-
consumers would recognize the applicant’s hologram as an nies in all sectors, from Big Pharma to Small Embroidery,
indicator of source.46 The TTAB stated that “the common use can rely on nontraditional marks—sounds, colors, shapes,
of holograms for non-trademark purposes means that con- features, interiors, motions, and even smells—to build and
sumers would be less likely to perceive applicant’s uses of embody their reputations. n
holograms as trademarks.”47
Therefore, the TMEP instructs that “in the absence of Endnotes
evidence of consumer recognition as a mark, the examin- 1. 514 U.S. 159, 170–71 (1995) (quoting McLean v. Fleming, 96
ing attorney should refuse registration on the ground that the U.S. 245, 254 (1877)).
hologram does not function as a mark.”48 Generally, if a holo- 2. 15 U.S.C. § 1127.
gram has more than one view, the examining attorney will 3. 514 U.S. at 174.
also refuse registration of the mark on the ground that the 4. 774 F.2d 1116, 1127–28 (Fed. Cir. 1985).
application seeks registration of more than one mark.49 5. U.S. Patent & Trademark Office, Trademark Manual of
Nevertheless, the USPTO allows registration of hologram Examining Procedure (TMEP) § 1202.05 (Oct. 2017).
marks where the application covers holograms of a particular 6. Wal-Mart Stores, Inc. v. Samara Bros., 529 U.S. 205, 211–12
design or shape. Examples include: (2000).
• Registration No. 3,045,251 (Jan. 17, 2006) for a holo- 7. In re Hudson News Co., 114 F.3d 1207 (Fed. Cir. 1997) (per
gram image at the center of a credit card for charge curiam).
card and credit card services; 8. In re Hudson News Co., 39 U.S.P.Q.2d 1915, 1923 (T.T.A.B.
• Registration No. 2,934,710 (Mar. 22, 2005) for a holo- 1996), aff’d, 114 F.3d 1207.
gram containing the words “FAIR & WHITE HEALTH 9. E.g., AstraZeneca AB v. Dr. Reddy’s Labs., Inc., 145 F. Supp. 3d
SECURITY LABO DERMA PARIS” for various per- 311 (D. Del. 2015). The authors represented AstraZeneca in this case.
sonal care products; 10. TrafFix Devices, Inc. v. Mktg. Displays, Inc., 532 U.S. 23, 32
• Registration No. 3,407,662 (Apr. 8, 2008) for a shield (2001).
in the form of a hologram for pharmaceutical prescrip- 11. Brunswick Corp. v. British Seagull Ltd., 35 F.3d 1527, 1534
tion pads; and (Fed. Cir. 1994).
• Registration No. 2,143,827 (Mar. 17, 1998) for a 12. In re Orange Commc’ns, Inc., 41 U.S.P.Q.2d 1036, 1042
metallic foil hologram for plastic pages for cards and (T.T.A.B. 1996).
photographs. 13. Saint-Gobain Corp. v. 3M Co., 90 U.S.P.Q.2d 1425 (T.T.A.B. 2007).
Continued on page 64
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
Ten Years after KSR,
Motivation to Combine Moves
Back into the Spotlight
By Chao Gao and Peter M. Jay
T
en years ago, the Supreme Court issued its seminal decision in KSR Inter-
national Co. v. Telelex Inc., rocking the world of patent practitioners by
decisively demoting the motivation to combine analysis, the primary criterion
for determining obviousness.1 Recently, however, the United States Court of Appeals
for the Federal Circuit (CAFC) has shown a renewed interest in the suficiency of
motivation to combine arguments relied on in an obviousness analysis. The decisions
from the CAFC discussed below provide a practical reminder that a proper motivation
to combine determination is essential to a well-reasoned conclusion of obviousness.
Image: iStockPhoto
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
Historically, courts utilized wildly inconsistent standards for agreeing that the TSM test provided helpful insight as to what
determining obviousness prior to the Patent Act of 1952.2 In an a person having ordinary skill in the art might have done at
effort to create a “stabilizing effect and minimize great depar- the time a claimed invention was made, the Supreme Court
tures which have appeared in some cases,”3 the drafters of the instilled a lexible approach for determining obviousness.
Patent Act of 1952 set out to “provide a standard according to Requiring a concentration on resolving the Graham factors
which the subjective decision [of obviousness] must be made.”4 and setting forth an explicit analysis in support of the ulti-
Out of that effort was born § 103 of the Patent Act of 1952, mate conclusion, the Supreme Court stated that “the analysis
which provided that “[a] patent may not be obtained . . . if the need not seek out precise teachings directed to the speciic
differences between the subject matter sought to be patented subject matter of the challenged claim, for a court can take
and the prior art are such that the subject matter as a whole account of the inferences and creative steps that a person of
would have been obvious at the time the invention was made to ordinary skill in the art would employ.”12
a person having ordinary skill in the art.”5 Thereafter, the United States Patent and Trademark Ofice
The issue of how to determine what would have been obvi- amended the MPEP to assert that the conclusion of obviousness
ous at the time the invention was made, however, continued should be determined in view of the Graham factors, and must be
to plague those prosecuting and examining patent claims. supported by an explicit and “clear articulation of the reason(s)
Attempting to bring further uniformity to the analysis, the why the claimed invention would have been obvious.”13 The pre-
viously all-powerful TSM test was replaced with seven exemplary
rationales for supporting a inding of obviousness. Although the
Strict reliance TSM test was not excluded altogether, it was relegated to last
place.14 And so, post-KSR, a teaching, suggestion, or motivation
to combine the cited references became an insigniicant and often
ignored rationale in obviousness determinations. Recent CAFC
on the TSM test decisions, however, appear to signal a potential shift marking the
revival of at least a lexible TSM requirement.
In In re NuVasive, Inc., the CAFC recently vacated a inal
written decision in an inter partes review (IPR) because the
was called into Patent Trial and Appeal Board (PTAB) failed to suficiently
articulate a motivation to combine prior art references.15 The
CAFC reviews such inal written decisions through the lens
of the Administrative Procedure Act (APA), whereby the stan-
question by KSR. dard for factual determinations is substantial evidence, and the
standard for legal determinations is de novo.16 Both standards
are relevant to the review of inal written decisions because the
PTAB must: (1) make the necessary indings and have an ade-
United States Court of Customs and Patent Appeals, the pre- quate evidentiary basis for its indings; and (2) examine the
decessor to the CAFC, asserted the rule that a combination relevant data and articulate a satisfactory explanation for its
of the prior art is not obvious “unless the art also contains action including a rational connection between the facts found
something to suggest the desirability of the proposed com- and the choice made.17 The CAFC found that the inal written
bination.”6 This rule, requiring that the applied art contain decision in NuVasive failed to meet these minimum standards.18
some teaching, suggestion, or motivation to combine the dis- A primary issue in the inal written decision in NuVasive
closures therein (TSM test), soon became revered as a vital was whether a combination of references rendered unpatent-
safeguard against improper hindsight reasoning.7 able a spinal fusion implant having radiopaque markers in the
Interestingly, the Supreme Court’s pivotal decision in Gra- medial plane (i.e., near the middle of the implant).19 During the
ham v. John Deere Co., which set forth the modern standard for IPR, the petitioner argued that it would have been obvious to
determining obviousness, did not include the TSM test among its include the radiopaque markers of the secondary reference in
essential factors.8 Nonetheless, courts continued to apply the TSM the implants of the primary references in order to provide “addi-
test as an integral indicator of obviousness.9 In fact, the TSM test tional information” regarding the location and/or orientation of
became so crucial to the obviousness analysis that it was added to the implant, both during surgery and after implantation.20 The
the Manual of Patent Examining Procedure (MPEP) in 1995 as patent owner responded by arguing that the reason articulated
the primary criterion for determining obviousness.10 (i.e., the “additional information”) is simply a vague explanation
In 2007, however, strict reliance on the TSM test was with no rational underpinning.21 Speciically, the patent owner
called into question by the Supreme Court in KSR.11 Although argued that the petitioner’s expert did not provide a rational
Chao Gao is a partner at Wenderoth, Lind & Ponack in Washington, DC, where his practice focuses primarily on procuring patents in the
chemical arts. He also regularly counsels a variety of domestic and international clients regarding all aspects of US patent law, including
providing infringement and validity opinions. He can be reached at cgao@wenderoth.com. Peter M. Jay is an associate at Wenderoth, Lind
& Ponack in Washington, DC, where he represents international and domestic clients in a variety of areas including patent prosecution and
counseling in the chemical arts. He can be reached at pjay@wenderoth.com.
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
explanation for what the “additional information” would be, and the examiner’s reasons for combining the applied art, rather
that the additional information would be redundant or even cause than merely focusing on the elements of the references them-
confusion.22 Although agreeing with the petitioner, the PTAB selves. In particular, PersonalWeb emphasizes that just
“never articulated why the additional information would beneit because two references can be combined does not necessarily
a [skilled artisan] when implanting a posterior lumbar interbody mean that one skilled in the art would have had a motivation
fusion implant.”23 The PTAB also “failed to explain the type of to do so. Also, an obviousness determination, even during
additional information a [skilled artisan] would obtain or how prosecution, cannot be supported by merely relying on “obvi-
the [skilled artisan] would use that information.”24 Therefore, ous improvements”36 or “common sense.”37
the CAFC held that the PTAB did not suficiently articulate a The CAFC decisions discussed above highlight the resurg-
motivation to combine the references.25 Accordingly, the CAFC ing focus on a well-articulated motivation to combine in
vacated the inal written decision of the PTAB because the supporting an obviousness determination. In practice, arguing
CAFC could not provide meaningful review of the motivation to insuficiency of motivation to combine can be dificult dur-
combine reasoning due to the insuficiency.26 ing prosecution because examiners tend to rely on the broadest
In PersonalWeb Technologies, LLC v. Apple, Inc., the CAFC statements of KSR. However, the CAFC has recently reminded
again addressed whether the PTAB had suficiently supported its the PTAB not only of the importance of the motivation analysis
conclusion of obviousness in an IPR.27 The petitioner, arguing that but also that it “knows how to meet [its] burden.”38 Therefore,
the claims were invalid for being obvious over a combination of recent CAFC decisions suggest that patent practitioners should
two references, asserted that a person having ordinary skill in the consider appeals where motivation to combine is a central issue
art “would have understood” that the combination thereof would during prosecution, and that the PTAB will carefully scrutinize
have achieved the claimed features.28 In its analysis, the PTAB examiners’ rationales for combining references. n
merely concluded: “We agree in this regard and are persuaded that
the combination of [the cited references] renders claims . . . unpat- Endnotes
entable under 35 U.S.C. § 103.”29 On appeal, the CAFC noted that 1. 550 U.S. 398 (2007); see also Michael Barclay, Some Thoughts
this “reasoning seems to say no more than that a skilled artisan, about KSR v. Telelex: The “Marketplace” Test for Obviousness,
once presented with the two references, would have understood SCOTUSblog (Apr. 30, 2007), http://www.scotusblog.com/2007/04/
that they could be combined. And that is not enough; it does not some-thoughts-about-ksr-v-telelex-the-marketplace-test-for-obvious-
imply a motivation to pick out those two references and combine ness/ (“[T]his is the most important patent case of the last 20 years,
them to arrive at the claimed invention.”30 Rooting its decision in and perhaps since the passage of the 1952 Patent Act.”).
the expansive and lexible approach set forth in KSR, the CAFC 2. See George M. Sirilla, 35 U.S.C. § 103: From Hotchkiss to
noted that it is important to clearly articulate why a person having Hand to Rich, the Obvious Patent Law Hall-of-Famers, 32 J. Mar-
ordinary skill in the art would have been motivated to combine the shall L. Rev. 437, 468–69, 472–73, 487, 501 (1999).
applied references “because inventions in most, if not all, instances 3. H.R. Rep. No. 82-1923, at 7 (1952).
rely upon building blocks long since uncovered, and claimed dis- 4. Giles S. Rich, The Principles of Patentability, 42 J. Pat. Off.
coveries almost of necessity will be combinations of what, in Soc’y 75, 89 (1960).
some sense, is already known.”31 5. Patent Act of 1952, § 103, 66 Stat. 792, 798.
Even though NuVasive and PersonalWeb were decided in the 6. In re Bergel, 292 F.2d 955, 956–57 (C.C.P.A. 1961).
context of a review of an agency decision under the APA, the 7. See KSR Int’l Co. v. Telelex Inc., 550 U.S. 398, 407 (2007);
underlying reasoning is also applicable during patent examina- In re Dembiczak, 175 F.3d 994, 998–99 (Fed. Cir. 1999) (“Our case
tion. For instance, in In re Van Os, the CAFC speciically applied law makes clear that the best defense against the subtle but power-
the reasoning from NuVasive to vacate and remand a PTAB deci- ful attraction of a hindsight-based obviousness analysis is rigorous
sion addressing an appeal during patent examination because application of the requirement for a showing of the teaching or moti-
the PTAB’s actions were “insuficiently or inappropriately vation to combine prior art references. Combining prior art references
explained.”32 In Van Os, the PTAB agreed with the examiner’s without evidence of such a suggestion, teaching, or motivation sim-
analysis that the claims at issue were obvious because combining ply takes the inventor’s disclosure as a blueprint for piecing together
the cited references “would have been ‘intuitive.’”33 However, the prior art to defeat patentability—the essence of hindsight.” (cita-
the CAFC held that “[a]bsent some articulated rationale, a ind- tions omitted)); ACS Hosp. Sys., Inc. v. Monteiore Hosp., 732 F.2d
ing that a combination of prior art would have been ‘common 1572, 1577 (Fed. Cir. 1984) (“Obviousness cannot be established by
sense’ or ‘intuitive’ is no different than merely stating the com- combining the teachings of the prior art to produce the claimed inven-
bination ‘would have been obvious.’ Such a conclusory assertion tion, absent some teaching or suggestion supporting the combination.
with no explanation is inadequate to support a inding that Under section 103, teachings of references can be combined only if
there would have been a motivation to combine.”34 Recogniz- there is some suggestion or incentive to do so.”).
ing the importance of safeguarding against hindsight reasoning, 8. See 383 U.S. 1, 17 (1966).
the CAFC explained that “[t]his type of inding, without more, 9. See In re Lee, 277 F.3d 1338, 1342–43 (Fed. Cir. 2002) (“The essen-
tracks the ex post reasoning KSR warned of and fails to identify tial factual evidence on the issue of obviousness is set forth in Graham v.
any actual reason why a skilled artisan would have combined the John Deere Co. and extensive ensuing precedent. The patent examination
elements in the manner claimed.”35 process centers on prior art and the analysis thereof. When patentability
In view of the decisions in NuVasive and PersonalWeb, turns on the question of obviousness, the search for and analysis of the prior
patent practitioners should be vigilant to consider carefully Continued on page 62
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
STRATEGIC
PREDICTIONS
Leveraging Art Unit Allowance
Rates to Drive the Selection of
Appeal Decision Makers
BY SAMEER VADERA AND KATE S. GAUDRY
pon reaching an impasse with an examiner during pros-
U
ecution of a patent, an applicant may initiate an ex parte
appeal of a rejection, thereby requesting review by the
Patent Trial and Appeal Board (PTAB).1 Such action can
result in considerable expense and delay.2 However, we
previously reported that a substantial portion of appeals
are terminated quickly by the examiner, via issuance of
either an allowance or ofice action.3 Thus, initiating an appeal process may
result in several different outcomes that signiicantly differ with respect to
delay, cost, and allowance prospects. Data more precisely identifying the prob-
ability of each outcome with respect to particular instances may allow applicants to
make more strategic and informed appeal-entry decisions.
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
Of those appeals for which a PTAB decision is rendered, 47 is the irst-line manager of an AU and is generally engaged
percent were reversed or reversed in part.9 However, the PTAB in day-to-day supervision of examiners’ work product.13 Fur-
decision is not completely predictive of the next event follow- ther, SPEs generally must sign off on appeal-related actions.
ing the decision. For example, of the applications for which To illustrate, a SPE must sign an examiner’s answer, thereby
full reversal PTAB decisions were issued, only 90 percent supporting a decision that the appeal should proceed toward
received next-action allowances. Of the remaining full rever- a PTAB decision. Conversely, if an examiner concludes
sals, 8 percent received new ofice actions and 2 percent either that the appeal should not move forward after reviewing the
had reopened prosecution via a request for continued exami- appellant’s appeal brief, the examiner must get his or her
nation (RCE) or had abandoned the application. Among the SPE’s approval before issuing a new ofice action or a notice
applications receiving a full afirmance decision, 68 percent of allowance.14 For SPEs inclined to allow applications, an
were then abandoned, while 28 percent were followed by an examiner’s proposal of pulling an appeal out of the appeal
RCE.10 cycle to allow the case may have a better-than-average chance
These corps-wide statistics thus indicate that iling an of being accepted—this would likely lead to a higher AU
appeal brief is considerably likely to lead to an examiner-ini- allowance rate. However, the converse is also true.
Before Examiner's Answer -
Correlation Between AU Allowance Rate & Exit Event
100%
90%
80%
70%
60%
Distribution of Exit Events
Examiner's Answer
50% Office Action
Notice of Allowance
Abandoned
RCE
40%
30%
20%
10%
0%
0-10% 10-20% 20-30% 30-40% 40-50% 50-60% 60-70% 70-80% 80-90% 90-100%
tiated expedient action rather than a delayed PTAB decision. Before Examiner’s Answer, AU Allowance Rate
Applicants disfavoring the potential multiyear delay of PTAB Is Predictive of Appeal Outcome
decisions may thus determine that an appeal is a desirable Extending our previous analysis, we investigated whether a
strategy. However, the above-presented statistics are corps- SPE’s allowance tendencies inluence an AU’s general allowance
wide. Ideally, an applicant could consider more speciic rate and would also inluence whether an appeal proceeds to the
predictions tied to characteristics of a particular application. PTAB. We assigned each appeal in our data to a bin relecting a
Using Art Unit Allowance Rates to Predict Sameer Vadera is a patent attorney at the Washington, DC, ofice
Appeal Outcomes of Kilpatrick Townsend & Stockton LLP. He focuses his practice
Our previous analysis of appeal data identiied that appeal on preparing and prosecuting patent applications in a variety of
outcomes can be more precisely predicted upon consider- technical ields, including wireless technologies, software, and
ing data for a particular art unit (AU) to which an application electronic devices. Kate S. Gaudry is a patent attorney at the
had been assigned.11 Such a result may be observed due to the same irm and ofice. She focuses her analysis on patent prosecution
required involvement of an AU’s supervisory patent examiner and counseling, with an emphasis on quantitative analysis of patent
(SPE) in the appeal cycle.12 SPEs naturally have a harmoniz- portfolios and strategic options and on prosecution for the
ing inluence on the examiners they oversee, because a SPE software, computer systems, and quantitative biology industries.
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
10 percent range of AU allowance rates. For example, the irst of the appeal cycle to his or her SPE.15 The SPE decides
bin includes all appeals that had been assigned to an AU with whether to approve (or initiate) pulling the appeal out of the
an allowance rate of 10 percent or below. Generally, each AU is appeal cycle.16 Lastly, the PTAB is the decision maker for
supervised by one or two SPEs, such that an AU’s allowance rate appeals that reach the end of the appeal cycle.17 As explained
is typically relective of a SPE’s allowance tendencies. We then in further detail below, our data suggests that applications in
calculated the portion of appeals within each bin for which vari- various AUs differ with regard to a probability of reaching
ous events occurred following iling of the appeal brief. Thus, particular types of decision makers. For example, applica-
we identiied the portions of the appeals that exited the appeal tions in high-allowance-rate AUs are less likely to reach the
process via an ofice action, notice of allowance, abandonment, PTAB decision maker. Figure 3 shows a decision tree for nav-
or RCE, and the portion of the appeals for which an examiner’s igating various appeal-entry scenarios outlined below.
answer was issued. Options to Engage
As shown in igure 1, the data supports our hypothesis: • Pre-Appeal Pilot
Higher Probability
C. • Interview with SPE/Examiner
the post-brief allowance probability is correlated with the AU Engage • P3 Pilot
of Reaching PTAB,
Lower Probability of
allowance rate. For example, in the two bins representing the Supervisor • File Appeal Brief E. Reopening Prosecution
lowest AU allowance rates, the percentage of briefs leading to AU% > PTAB% Reach
a next-event allowance was less than 5 percent. Meanwhile, Target: Reopen Pros. PTAB
EA% < AU% & PTAB%
the allowance probability was less than 30 percent for the two
bins representing the highest AU allowance rates. A. D.
Final AU% < PTAB%
Office Action Target: Reach PTAB File Appeal
Issued Brief
T
he United States Patent and Trademark Ofice’s foreign legal landscapes, and may be able to provide direct
(USPTO’s) intellectual property (IP) attachés serve assistance with speciic IP-related problems located in the
as a valuable resource in today’s globalized world. attaché’s region of responsibility.
IP attachés are US diplomats with IP expertise Attachés are resources who often listen and respond to
assigned to US embassies and consulates through- questions or concerns that US stakeholders have about pur-
out the world. Their expertise and experience facilitate their suing an investment in a particular area of the world. For
success by allowing them to address numerous topics, from example, recently in Brazil, a major US fashion label that
broad policy issues to speciic problems, on behalf of prac- manufactures shoes for export to the United States wished
titioners and US stakeholders. Consequently, the IP attachés to open retail stores in Brazil and make its brand available to
can be a valuable resource—to US rights holders, practitio- Brazilian consumers. However, the US company was con-
ners, and their clients—by virtue of their unique knowledge, cerned about the possibility of counterfeit products being sold
connections, and ability to assist US stakeholders who are locally in Brazil. The IP attaché in Rio de Janeiro met with
facing IP-related challenges throughout the world. the company’s import-export director to provide information
IP attachés have a wealth of information available to and guidance on how the company could enforce its IP rights
them. They are not limited to their own IP knowledge, but under Brazilian law. The attaché’s information allayed the
can draw upon the USPTO’s resources and expertise. There company’s concerns about counterfeiting, and it subsequently
is a constant line of communication between the attachés undertook the successful launch of its retail stores in Brazil.
and the USPTO. The USPTO Ofice of Policy and Interna- IP attachés are also there to counsel rights holders on
tional Affairs, within which the IP Attaché Program operates, options for enforcing IP rights in each country or region.
has teams of specialized patent, trademark, copyright, and Every government has its own approach to stakeholder
enforcement attorneys who provide additional support and engagement and enforcement. Certain governments prefer
guidance to the attachés. The attachés also work closely with that rights holders work through local counsel, while other
other US agencies in their regions. governments are eager to engage with international compa-
nies directly.
Information, Assistance, On-the-Ground Counsel This on-the-ground knowledge worked to the advantage of
IP attachés can provide information to practitioners and their another US irm, a Tennessee-based furniture company that
clients regarding the protection, enforcement, licensing, and manufactured its products in China. The company’s former
understanding of IP rights throughout the world. Attachés can original equipment manufacturer in China had obtained 13
assist practitioners and their clients in many ways, whether Chinese design patents, and used them to block the compa-
the client is already in a foreign market or wishes to enter a ny’s other manufacturers from making and exporting products
new area of the world. US stakeholders can beneit from the for the US company. The IP attaché in Guangzhou, China,
attaché’s knowledge of the IP environment in a host coun- met with the company’s CEO and provided information
try or region. Attachés can assist rights holders in navigating and guidance on China’s patent invalidation process and the
workings of its IP judicial system. The attaché also provided
suggestions on how the company could work with relevant
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
government authorities. One week after the client discussed
the situation with the attaché, three containers of furniture
were released for export by Chinese customs oficers. The leaders eventually agreed to allow the US company to
company then took steps to invalidate the Chinese design pat- retrieve its proprietary items.
ents and to fulill an additional $3.5 million in orders.
Many US companies encounter legal obstacles when Counterfeiting: Often a Concern
attempting to expand their business overseas. If a client’s Counterfeiting is an issue that the IP attachés encounter
business is hindered by foreign laws and regulations in a frequently. If a practitioner has a client that is having dif-
speciic country, an attaché may be able to help. One of the iculties with counterfeiting and piracy and is unable to
attaché’s roles is to advocate for changes in policies, laws, enforce its IP rights in various countries, an attaché may be
and regulations relating to intellectual property that are able to help educate host-government oficials on IP mat-
advantageous to US stakeholders. US stakeholders can help ters. This includes providing training to judges, prosecutors,
attachés to better understand the legal and regulatory issues patent and trademark examiners, customs oficials, police
they are facing. Thus, the attachés wish to hear about the spe- oficers, and policy makers. Such training can provide a bet-
ciic challenges that US businesses and practitioners face, and ter understanding of the US government’s experience with
to discuss with them possible solutions for the future. IP matters, increase awareness of accepted world standards
While many practitioners and companies employ foreign and practices, and, ultimately, enhance the effectiveness of
counsel throughout the world, the local foreign counsel often IP protection in a given country or region. Also, by training
do not have the same in-depth knowledge about the host gov- oficials of a host country, issues that clients may face can be
ernment, nor access to it, as does an attaché. They also do not alleviated or better understood.
have the support and resources of other US government agen- Because the attachés participate in regular meetings with,
cies. Unlike some local foreign counsel, the attachés often and training programs for, IP enforcement oficials in many
have a direct line of communication with the host government regions, the attachés know exactly who to contact in a variety
and can directly approach its oficials regarding problems US of situations. For example, if a US company obtains detailed
stakeholders are facing. The IP attaché can also raise spe- information about counterfeit shipments entering a country,
ciic situations with foreign government oficials when there the IP attaché can often direct the company to the oficials it
appears to be a systematic law in the host country’s IP pro- needs to contact if it wishes to stop the shipment.
tection and enforcement regime. In one instance, a California-based electronics manufacturer
Sometimes, such a direct approach will bring a reason- known for its high-performance audiovisual products ran into
ably quick resolution. An example is the case of a US apparel a counterfeiting problem when the company’s popular head-
maker that was working with a factory in the Pearl River phones were being produced and sold illicitly in Thailand. The
Delta region of southern China. When the manufacturing IP attaché in Bangkok explained the potential remedies under
facility abruptly shut down and the owners disappeared, the Thai law to the company, and introduced the company’s secu-
US company became entangled in the Chinese company’s rity oficials to Thai customs oficers and economic crime
bankruptcy proceedings, and much of the US company’s police. Thanks to the attaché’s help, shipments of the counter-
IP-protected equipment—including tooling and dies—was feit headphones were successfully seized by Thai oficials.
locked inside the shuttered factory. The IP attaché in Guang-
zhou worked with the State Department’s economic oficers Educating the Public
and the US Consulate’s Chinese staff to reach out to local Another role of an attaché is to educate the public on intel-
authorities in China, explaining the US company’s predica- lectual property. Attachés are available to assist with, and
ment. After a lengthy series of discussions, the municipal develop, grassroots support for US policy positions by
Dominic Keating is the director of the IP Attaché Program at the USPTO. He provides legal and policy direction to IP attachés based in
Brazil, India, China, Switzerland, Thailand, Kuwait, Belgium, and Mexico. From 2010 to 2011, he was a patent attorney in the USPTO’s Ofice
of Policy and External Affairs, and led a team of 12 attorneys to address IP issues in South Asia. He also headed a task force to reform the
USPTO’s IP Attaché Program. From 2006 to 2010, he served as the irst secretary for intellectual property in the US Embassy in New Delhi,
India, where he promoted high standards of IP protection and enforcement in India and other South Asian countries. He was awarded a Silver
Medal by the US Secretary of Commerce for his work. He can be reached at dominic.keating@uspto.gov.
Image: iStockPhoto
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
presentations by two federal jurists—one a trial judge, the other
an appellate judge. All of the participants emphasized the critical
role that intellectual property plays in national development and
conducting public awareness programs on intellectual prop- economic growth. Following the awareness program, China has
erty. The programs might include professors, local oficials, begun to implement, on a limited-time basis, some long-stand-
businesspeople, and students. Such information programs ing remedies and litigation tools of the US legal system. These
have been successful and well received throughout the world. include issuance of temporary injunctions and evidentiary pres-
These public awareness programs can bring changes to the ervation orders, and publishing redacted opinions that prevent
ways that intellectual property is protected and enforced. For disclosure of sensitive or proprietary information to the public.
example, in Guangzhou, China, the attaché organized a program To learn more about the USPTO’s IP Attaché Program and
on the importance of intellectual property in advancing a nation’s how you can contact an IP attaché, visit the program’s web-
economy. It included a presentation by the attaché as well as site at www.uspto.gov/ipattache. n
speakers from the provincial and local courts, the provincial IP
ofice, Chinese academics and IP practitioners, and Chinese and
foreign rights holders. It also featured a mock US IP trial, with
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
USPTO IP ATTACHÉS AROUND THE WORLD
Currently, the USPTO has 13 attaché positions stationed throughout the world available to assist practitioners and US stakeholders (see
table). Most of the attachés cover a wider region than just the country in which they are posted. Consequently, the attaché’s knowledge and
connections can beneit US stakeholders in multiple countries.
IP attachés are US diplomats with IP expertise assigned to US embassies and consulates throughout the world. Their expertise and experience
facilitate their success by allowing them to address numerous topics, from broad policy issues to speciic problems, on behalf of practitioners
and US stakeholders. Consequently, the IP attachés can be a valuable resource—to US rights holders, practitioners, and their clients—by virtue
of their unique knowledge, connections, and ability to assist US stakeholders who are facing IP-related challenges throughout the world.
Brazil Argentina, Brazil, French Guiana, Guyana, Paraguay, Suriname, Uruguay, and Venezuela
China (Guangzhou) Most of southeastern China, including Fujian, Guangdong, Guangxi Provinces, and Hainan Island
China (Shanghai) East China and Shanghai consular area provinces (Jiangsu, Zhejiang, and Anhai)
India South Asia (India, Pakistan, Bangladesh, Nepal, Bhutan, Sri Lanka, and Maldives)
Switzerland (UN) World Intellectual Property Organization (WIPO) and the United Nations (UN)
Southeast Asia and ASEAN (Brunei, Burma, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore,
Thailand Thailand, and Vietnam)
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
Excusez mon français
(Pardon My French)
Trademarks in Commercial
Advertising in Québec in Light
of the Recent Amendments to the
Regulations under the Charter of
the French Language
By François Larose
T
he Canadian province of Québec is famous for its joie de vivre and cul-
ture—being the birth place of singer Céline Dion, movie director Denis
Villeneuve, the Cirque du Soleil, and delicacies such as poutine. It is
also known for its signiicant French-speaking population. Maintaining
French as the language of the land is not an easy task when its population is sur-
rounded by over 300 million English-speaking neighbors, and thus, according to
many, requires strict laws.1
This is why Québec adopted, 40 years ago, on August 26, 1977, the Charter of
the French Language (Charter),2 a unique provincial law that declares French as
the oficial language of Québec. The Charter’s objective, set out in its preamble,
is “to make French the language of Government and the Law, as well as the nor-
mal and everyday language of work, instruction, communication, commerce and
business.” It requires entities including schools, government agencies, and busi-
nesses to use French in their communications with the public.
Over its existence, the Charter has been criticized and even challenged before
the courts, but it has also shown to be economically proitable3 and to have con-
tributed signiicantly to the protection of the French language in Québec. In 2015,
the Québec Court of Appeal reafirmed the importance of protecting French lan-
guage in Québec, notably through public signage:
For reasons that are known and are no longer disputable, promoting and protect-
ing the French language is, in Québec, an established priority responding to a real
and persistent need. The use of French in public is one of the pivotal points of this
policy: “Public signs and posters and commercial advertising shall be solely in the
François Larose is a partner with Bereskin & Parr LLP in Montréal, Canada. His practice
focuses on all aspects of trademark law in addition to licensing and related agreements,
regulatory, such as Charter of the French Language issues, and intellectual property
litigation. He may be reached at larose@bereskinparr.com.
Image: iStockPhoto
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
French language” or in a manner which ensures the marked the city of Montréal where many consider that French is his-
predominance of the French, states section 58 of the Charter, torically losing ground to other languages, especially English.
which sets out a principle that ensures that the reality of Qué-
bec society is relected in its “visage linguistique.”4 Commercial Signage Rule: Size Does Matter
The rule for public commercial signage is different from the
The Charter applies to all provincially regulated busi- general rule. It is dealt with in section 58 of the Charter:
nesses in Québec, but might also be applicable to federally
regulated businesses in Québec, such as banks, telecommuni- Public signs and posters and commercial advertising must be
cation companies, airlines, and maritime transport.5 in French.
Chapter VII of the Charter deals with the language of
commerce and business. It applies to inscriptions on products They may also be both in French and in another language
and packaging; on commercial publications, software, toys, provided that French is markedly predominant.
and games; on predetermined contracts, forms, invoices, and
receipts; commercial public signage; and business names.6 However, the Government may determine, by regulation, the
The Charter does not prohibit the use of other languages—in places, cases, conditions or circumstances where public signs
fact, it even permits the exclusive use of languages other than and posters and commercial advertising must be in French
French, including trademarks, as will be discussed below. only, where French need not be predominant or where such
This article will focus mainly on the requirements of using signs, posters and advertising may be in another language only.
French when a trademark in a language other than French appears
in commercial signage. These provisions have been the subject of As per the general rule, French is required on public signage.
controversy in the past few years, and changes were made last year Where the Charter does not require the use of French exclu-
that affect all businesses with non-French brands and an address in sively, other languages can also be used together with French.16
Québec. But, let’s irst start with an overview of the general rule. However, French must be “markedly predominant.”17 “Markedly
predominant” has been speciied by the Regulation Deining the
Use of French: General Rule Scope of the Expression “Markedly Predominant” for the Pur-
The general rule is simple: all commercial text must be in poses of the Charter of the French Language18 adopted under
French. Where the Charter authorizes texts or documents both in the Charter. It provides that French is markedly predominant
French and in one or more other languages, the French version where the text in French has a much greater visual impact than
must be displayed at least as prominently as the other language.7 the text in the other language. It also gives guidance for signs
For example, text on goods or their packaging can be in where French and another language appear, in that French will
French and in another language, as long as the text in the other be deemed to have a much greater visual impact if:
language is not given greater prominence than the French text.8 • On the same sign or poster, the space allotted for and
There are no speciic rules as to the font, color, or location of the the characters of the French text are at least twice as
text in each language—they can be one on top of the other, or large as the space/text for the other language;
side by side, or even on opposite sides of the good or package. • On separate signs or posters of the same size, the signs
Text in commercial publications, such as “[c]atalogues, and posters in French are at least twice as numerous
brochures, folders, commercial directories and any simi- as those bearing the text in the other language and the
lar publications,” must be in French.9 “Similar publications” French characters are at least as large as those in the
include websites10 and probably social media.11 These pub- other language; and
lications can be bilingual or in two separate unilingual • On separate signs or posters of a different size, the
versions, as long as the French version is “available under no signs and posters in French are at least as numerous as
less favourable conditions of accessibility and quality than those bearing the text in the other language and at least
the version in the other language.”12 twice as large as those in the other language and the
French characters are at least twice as large as those in
Commercial Public Signage (Section 58) and the the other language.19
“Recognized” Trademark Exceptions In addition, the other characteristics of the sign or poster must not
On November 24, 2016, almost 30 years after being held have the effect of reducing the visual impact of the text in French.
unconstitutional by the Supreme Court of Canada as they For example (same sign, space allotted for and characters
were then drafted,13 the revised provisions of the Charter of French at least twice as large):
imposing French on commercial signage got a facelift, tight-
ening up the exception that allows trademarks recognized
under the federal Trade-marks Act14 to be exclusively in a VENTE DE FEU—TOUT DOIT PARTIR!
language other than French.15 While such trademarks may
remain exclusively in a language other than French, a “sufi- FIRE SALE—EVERYTHING MUST GO!
cient presence” of French must now be added, accompanying
or surrounding the mark. These new requirements will be pre- Simply posting the French version before a version in another
sented below. The amendments’ purpose is to increase the language on commercial signage does not meet the mark-
French landscape in the province of Québec, particularly in edly predominant criteria. In fact, “[w]hen it comes to the
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
language of signs and the marked predominance of the using the mark in Québec or face the uncertainty of receiving
French language, size does matter.”20 a complaint during that time.
Exceptions: The “Recognized” Trademark, and the Ofice’s The Ofice’s New Change in Interpretation:
First Change in Interpretation When a Trademark Is Not a Trademark, and the
As indicated above, there are exceptions pursuant to which Best Buy Decision
the text on public commercial signage can be exclusively in
a language other than French. These are provided at sections Trademarks on Storefront Signage
22 to 25 of the Regulation Respecting the Language of Com- The Ofice did not completely disregard the teaching of the
merce and Business (Regulations)21 and include advertising above-mentioned Centre sportif St-Eustache decision. This
for cultural events, a media outlet that broadcasts in that other decision also conirmed that trade names are different from
language, advertising of an event—and during that event— trademarks and do not beneit from the trademark excep-
such as an exhibition for a specialized or limited public, tion—a trade name on a storefront window must thus comply
foreign irm names (not doing business in Québec), a place with the markedly predominant rule.
name, a family name, and a recognized trademark. The Ofice sided with the last part of that decision, and
The commonly accepted interpretation of this “recog- again changed a long-standing interpretation of the Char-
nized” trademark exception was that translation was not ter, this one on the use of trademarks on storefront signage:
required if it could be shown that any “mark” was recognized suddenly, a trademark on storefront signage was no longer
as a trademark, whether registered or unregistered, as both considered by the Ofice as a mere trademark, but rather as
are recognized by the Trade-marks Act. While it would surely a business name that does not beneit from the trademark
be easier to show that a mark was “recognized” if the mark exception. A trade name’s distinctive element may be in a
was registered, or an application was pending, it was open for language other than French, on the condition that there are
anyone to argue that the presentation or use of the mark was additional French descriptive elements.23
such that consumers would recognize it as a trademark. One can ind it unfortunate to see a government institution
From time to time, the Ofice québécois de la langue fran- cherry-picking the teachings of a court decision and negating
çaise (Ofice), the governmental body in charge of protecting another clearly stated teaching of the same decision—with-
the French language, issues an annotated version of the Char- out even challenging that decision in the Québec Court of
Suficient Presence of French Some information, however, will not be taken into account
On November 24, 2016, the Québec government’s response came when assessing the suficient presence of French: business
into force: the Regulations were amended to force businesses with hours, telephone numbers, and addresses; numbers and per-
storefront signage bearing only non-French trademarks to add centages; and deinite, indeinite, and partitive articles (e.g.,
other text, such that there is a “suficient presence of French.” Five le, la, un, une, les, or des).
new sections were added to the Regulations.
New section 25.1 states the new general rule: Markedly Predominant
These new rules do not change one fundamental rule: the
Where a trade mark is displayed outside an immovable only markedly predominant rule of French text on commercial sig-
in a language other than French under paragraph 4 of section nage. This means that if the other text added to the signage
25, a suficient presence of French must also be ensured on also appears in a language other than French, French has to
the site, in accordance with this Regulation. be, for example, twice the size of the text in the other lan-
guage. For example:
For the purposes of the irst paragraph, the presence of French
refers to a sign or poster with: MAD COW
Nous aimons notre bœuf à mort
(1) a generic term or a description of the products or services We Love our Beef to Death
concerned;
The rules regarding the scope of “markedly predominant”
(2) a slogan; were also amended to clarify that when assessing the much
greater visual impact of French text, the exceptions, such as
(3) any other term or indication, favouring the display of those listed at section 25 of the Regulations, are not to be
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
taken into account. This means that in assessing the visual c. Waldie-Reid, 2002 CanLII 63270 (C.Q.); Québec (Procureur
impact, the Ofice will look at all elements except those for général) c. Hyperinfo Can. Inc., 2001 CanLII 16493 (C.Q.).
which an exception is provided in the Charter or its Regula- 11. Section 52 applies to all commercial publications provided
tions and determine if the remaining text complies with the it is aimed at making commerce on the territory of Québec. Waldie-
markedly predominant rule. For example, a family name that Reid, 2002 CanLII 63270.
is also a trademark will not be subject to the new rules.31 12. Regulation Respecting the Language of Commerce and Busi-
While all new outdoor signage must be in compliance with ness, C.Q.L.R., c C-11, r 9, s 10.
these new rules, the transitional provisions give existing signs 13. Ford v. Québec (Attorney Gen.), [1988] 2 S.C.R. 712 (hold-
or new signs for businesses that are part of a franchise system a ing the initial provisions on public commercial signage providing
three-year period (i.e., before November 24, 2019) to comply. that such commercial advertising had to be solely in French to be
While these new measures will certainly mean additional unconstitutional and an infringement of the freedom of expres-
formalities for the added French text on storefront signage, sion). It was actually section 58’s third version, but, as with the two
multinational companies doing business in Québec can previous versions, the general rule was that public signage and com-
breathe a sigh of relief because the new rules do not force mercial advertising had to be exclusively in French.
them to alter their trademarks by requiring a translation. Such 14. R.S.C. 1985, c T-13.
a stringent change would surely have elicited another round 15. More speciically, section 58 of the Charter was not amended,
of constitutional contestation because the Trade-marks Act is but new sections 25.1 to 25.5 of the Regulation Respecting the Lan-
of federal jurisdiction. guage of Commerce and Business, C.Q.L.R., c C-11, r 9, adopted
From a marketing perspective, however, these new under the Charter, came into force, and provide for new require-
changes can represent an opportunity for anyone with com- ments of French on storefront signage.
mercial activities in Québec. Businesses should appeal to 16. C.Q.L.R., c C-11, s 89.
their targeted customers and convey messages in their lan- 17. It is interesting to note that the markedly predominant idea
guage to better reach them. They can thus improve their was in fact suggested by the Supreme Court of Canada in the Ford
image and increase visibility. decision, [1988] 2 S.C.R. 712, para. 73: “Thus, whereas requiring
Some businesses have even gone all out and translated the predominant display of the French language, even its marked
their main trademark, and done it with quite success, such as predominance, would be proportional to the goal of promoting and
Staples (Bureau en Gros), KFC (PFK), and Running Room maintaining a French ‘visage linguistique’ in Québec and therefore
(Coin des coureurs). Their contribution to Québec’s visage justiied under the Québec Charter and the Canadian Charter, requir-
linguistique surely does not go unnoticed. In any event, the ing the exclusive use of French has not been so justiied.”
addition of suficient French can add a certain je ne sais quoi 18. C.Q.L.R., c C-11, r 11.
to businesses’ well-known brands. n 19. Id. at ss 2–4.
20. Québec (Attorney Gen.) v. 156158 Can. Inc. (Boulangerie
Endnotes Maxie’s), 2015 QCCQ 354, para. 103.
1. For a summary of Québec’s historical legislative efforts to 21. C.Q.L.R., c C-11, r 9.
protect French language, see Magasins Best Buy ltée c. Québec 22. Centre sportif St-Eustache c. Québec (Procureur général),
(Procureur général), 2014 QCCS 1427, paras. 1–7. 2009 QCCS 3307.
2. C.Q.L.R., c C-11. 23. C.Q.L.R., c C-11, s 67; C.Q.L.R., c C-11, r 9, s 27.
3. According to the following study, knowledge of several lan- 24. Among the consequences, absent the francization certiicate,
guages (such as French and English) multiplies the number of such a business would no longer be able to be hired on government
potential business partners and thus stimulates commerce and pros- contracts.
perity: Alan Arcand, Conference Bd. du Can., Le Canada, le 25. Magasins Best Buy ltée c. Québec (Procureur général), 2014
bilinguisme et le commerce, at iii, 38 (2013) (“La connaissance QCCS 1427.
généralisée du français au Nouveau-Brunswick et au Québec stimule 26. An Act Respecting the Legal Publicity of Sole Proprietor-
le commerce entre ces provinces et les pays francophones [General- ships, Partnerships and Legal Persons, C.Q.L.R., c P-45, s 17.
ized knowledge of French in New Brunswick and Québec stimulates 27. Best Buy, 2014 QCCS 1427, para. 107.
trade between these provinces and French-speaking countries].”). 28. C.Q.L.R., c C-11, r 9, s 25(1).
4. Québec (Procureure générale) c. Magasins Best Buy ltée, 2015 29. Magasins Best Buy ltée v. Québec (Procureur général), 2015
QCCA 747, para. 7. QCCA 747.
5. David Robitaille & Pierre Rogué, La Charte de la langue fran- 30. “Outside an immovable” includes signs inside the premises
çaise: une entrave aux activités essentielles des entreprises privées that are intended to be seen from outside, and on an independent
de compétence fédérale au Québec?, 43 R.D.U.S. 645, 654 (2013). structure, such as a totem-type structure, if there is no other outside
6. C.Q.L.R., c C-11, ss 51, 52, 52.1, 54, 55, 57, 58, 63–71. sign or poster on which the trademark appears and if no other trade-
7. Id. at s 91. mark appears on the totem. It also includes a permanent stand or
8. Id. at s 51. counter, or premises in a mall, if the sign is made to be seen by cus-
9. Id. at s 52. tomers walking by. C.Q.L.R., c C-11, r 9, s 25.2.
10. Québec (Procureur général) c. Aroyan, 2006 QCCQ 31. In addition, nowhere is it provided that the trademark rules
6922; Québec (Procureur général) c. Produits métalliques C.M.P. supersede the other exceptions, such as a family name. See Best Buy,
Ltée, 2004 CanLII 48901 (C.Q.); Québec (Procureur général) 2014 QCCS 1427, para. 131.
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
Patenting the Future of Medicine
The Intersection of Patent Law and
Artificial Intelligence in Medicine
By Susan Y. Tull
Image: iStockPhoto
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
rtiicial intelligence (AI) is rapidly transforming “Evolutionary computation is the general term for several
A
the world of medicine, and the intellectual prop- computational techniques based on natural evolution process
erty directed to these inventions must keep pace. that imitates the mechanism of natural selection and sur-
AI computers are diagnosing medical conditions vival of the ittest in solving real-world problems.”19 Genetic
and disorders at a rate equal to or better than their algorithms are the most widely used form of evolutionary
human peers, all while developing their own soft- computation in medicine, creating numerous solutions to a
ware code and algorithms to do so. These recent single problem, and then evolving those solutions from one
advances raise issues of patentability, inventorship, generation to the next to arrive at the best solution.20 Evolu-
and ownership as machine-based learning evolves. tionary computation has been used in diagnosis, prognosis,
imaging, and signal processing.21
Artiicial Intelligence
In the realm of AI, what was once science iction is becom- Questions Surrounding Patenting AI in Medicine
ing fact. AI is “a ield of science and engineering concerned As the use of AI in medicine becomes even more prevalent,
with the computational understanding of what is commonly the patent system must answer increasingly dificult ques-
called intelligent behavior, and with the creation of artifacts tions regarding the protection afforded these technologies.
that exhibit such behavior.”1 While the concept of AI is not The irst, and perhaps most obvious, question is that of sub-
new,2 the last three decades have marked a surge in the devel- ject matter eligibility. With the Supreme Court decisions in
opment of medical AI.3 AI techniques utilized in medicine Alice and Mayo, the hurdle to meet subject matter eligibility
include artiicial neural networks, fuzzy expert systems, evo- has grown ever higher.22
lutionary computation, and hybrid intelligent systems.4 In Mayo, the Supreme Court found that claims directed to
Artiicial neural networks are formed of interconnected the relationships between concentrations of certain metab-
computer processors that perform parallel processing.5 These olites in the blood and the likelihood that a drug dosage
networks can learn from historical examples and known patterns will prove ineffective or cause harm were not subject mat-
and are thus used extensively in clinical diagnosis and image ter eligible under § 101.23 According to the Court, “[b]eyond
analysis.6 Neural networks have been used for diagnosing pros- picking out the relevant audience, namely those who admin-
tates as benign or malignant, cervical screening, and imaging ister doses of thiopurine drugs, the claim simply tells doctors
analysis (including radiographs, ultrasounds, CTs, and MRIs), to: (1) measure (somehow) the current level of the relevant
as well as for analyzing heart waveforms to diagnose conditions metabolite, (2) use particular (unpatentable) laws of nature
such as atrial ibrillation and ventricular arrhythmias.7 (which the claim sets forth) to calculate the current toxicity/
For example, researchers at Stanford University trained a ineficacy limits, and (3) reconsider the drug dosage in light
neural network to classify skin lesions into either benign or of the law.”24 Finding the claims lacked patent-eligible subject
malignant groupings based on known images and outcomes.8 matter, the Court concluded that the claims provide “instruc-
The researchers started with an algorithm developed by Google tions [that] add nothing speciic to the laws of nature other
to perform image recognition9 and then trained their neural net- than what is well-understood, routine, conventional activity,
work to recognize skin cancer using 129,450 clinical images of previously engaged in by those in the ield.”25
2,032 different diseases.10 The neural network was then tested Alice addressed the holding of Mayo, enunciating a two-
against board-certiied dermatologists on clinical images that step test for subject matter patent eligibility: (1) determine
had been conirmed through biopsy.11 The AI performed on par whether the claims are directed to a patent-ineligible concept
with the certiied dermatologists, demonstrating that the AI was (laws of nature, abstract ideas, and natural phenomena); and
capable of classifying skin cancer with the same level of com- (2) determine whether the claim’s elements, considered both
petence as the trained dermatologists.12 individually and as an ordered combination, transform the
As yet another example, digital health start-up Cognoa utilized nature of the claims into a patent-eligible application.26
machine learning AI to diagnose developmental delays in children These two recent Supreme Court cases present a hurdle
based on information and videos sent in by parents.13 The machine that medical AI inventions will have to overcome in order to
learning model was trained using 891 autism cases and 75 non- receive patent protection. Current AI medical device/system
autism controls to recognize autism behaviors in order to make a patents are directed to both the methods and apparatuses that
diagnosis.14 The AI was found to have a sensitivity of 89.9 percent perform the above-described analyses. Many AI medical pat-
in detecting autism, showing promise as a screening tool.15 ents are directed to the AI algorithms and the machines used
Fuzzy logic AI rests on the premise that everything is to generate those algorithms.27
a matter of degree, utilizing a continuous set membership For example, Cognoa, described above, has iled a patent
from 0 to 1 instead of the traditional Boolean logic that uses application directed to “methods and apparatus to determine
sharp distinctions between 0 and 1 to deine the algorithm.16 developmental progress with artiicial intelligence and user
Because diseases, symptoms, and diagnoses are described
in imprecise terms, fuzzy logic can recognize “partial truth Susan Y.Tull is a partner at Finnegan. With years of experience in
logics,” beyond just the true and false values applied in tra- patent litigation, she has been involved in all phases and forums of
ditional programming.17 Fuzzy logic AI has been applied to litigation. Her patent litigation, appeals, and post-grant proceedings
cancer diagnosis for lung cancer, acute leukemia, breast can- practices focus on technologies related to medical devices and
cer, and pancreatic cancer.18 consumer products. She may be reached at susan.tull@innegan.com.
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
input.”28 The claims of the Cognoa application generally pro- occurring phenomenon into patent-eligible subject matter.33
tect an apparatus “for evaluating a subject for risk of having a The court found that the second step was not met because the
developmental disorder”29 Dependent claims further deine the method steps “were well-understood, conventional, and rou-
hardware used and processing steps followed in performing tine,” despite acknowledging their breakthrough nature.34
that evaluation.30 The broadest claims, however, do not require Although the Supreme Court cautioned against construing the
that level of detail. Claim 1, for example, is as follows: exclusionary principle of § 101 overbroadly, “lest it swallow all of
patent law,”35 many believe it has done just that in the life sciences
An apparatus for evaluating a subject for risk of having a and medical spaces.36 The concurring opinion in Ariosa echoed
developmental disorder among two or more related develop- these concerns, stating that “[b]ut for the sweeping language in the
mental disorders, the apparatus comprising: Supreme Court’s Mayo opinion, [there was] no reason, in policy
or statute, why this breakthrough invention should be deemed pat-
a processor comprising a tangible medium conigured with ent ineligible.”37 The same reasoning could well curtail the patent
instructions to, protections afforded medical AI absent a change in Supreme Court
precedent or statute. Until such a change occurs, AI inventors and
present a question to the subject, the question conigured owners must draft their patents with an eye to this two-step test,
to assess a clinical characteristic related to the two or more including features related to the AI in the claims, such as detailing
related developmental disorders, the computing or mathematical techniques applied by the system
or describing how the computer interacts with other components
receive an answer corresponding to the clinical characteristic to drive the AI processing.
of the subject related to the two or more related developmen- In addition to § 101 concerns, AI in medicine raises ques-
tal disorders; and tions of inventorship and ownership in patent law. The US
patent system only recognizes individuals as inventors,38 not
determine, in response to the answer, whether the subject is at companies39 or machines.40 But with AI, it may be the machine
greater risk of a irst developmental disorder or a second devel- that is taking the inventive leap, not the human programmer.
opmental disorder of the two or more related developmental Recently, both Google and Facebook have seen AI develop its
disorders, with a sensitivity and speciicity of at least 80%.31 own language to perform the assigned tasks, eschewing known
languages in favor of a more eficient means of communica-
AI in medicine tion.41 As the use of AI grows in medicine and the life sciences,
it is more and more likely that the AI will be the entity tak-
ing the inventive step, drawing new conclusions between the
raises questions of observed and the unknown. Indeed, current AI systems develop
their own code as a result of the system’s training.42 If that
is the case, the United States Patent and Trademark Ofice
inventorship and (USPTO) and the courts will have to decide whether the cur-
rent Patent Act encompasses computer-based inventors, and if
ownership in patent law. not, who among the humans responsible for the AI should be
considered an inventor.43 The list of possible human inventors
includes the AI software and hardware developers, the medical
These AI inventions in medicine are directed to diagno- professionals or experts who provided the data set with known
sis and prognosis, relating known images to new cases and values or otherwise provided input into the development of the
extrapolating based on the similarities or differences between AI, and/or those who reviewed the AI results and recognized
the two. In some instances, this is the same process followed that an invention had been made.
by a doctor or medical expert, just with greater eficiency or Similarly, AI may confuse the question of ownership for
accuracy. The steps for diagnosis struck down in Mayo echo medical inventions generated by the AI itself. Patent ownership
the steps taken in many medical AI algorithms. often turns on the question of inventorship44 (followed by assign-
Indeed, the Federal Circuit has already found revolution- ment), and thus will be equally complicated when AI develops
ary diagnostic technology to be patent-ineligible subject matter its own code and conceives its own inventions. Given that AI
under the Mayo/Alice framework. In Ariosa Diagnostics, Inc. continues to advance after its initial programming, the question
v. Sequenom, Inc., the court concluded that a novel method of inventorship and ownership may have to be answered years
of prenatal diagnosis of fetal DNA was not directed to pat- after the initial system programming. Development, assignment,
ent-eligible subject matter, despite agreeing that the claimed and employment contracts will have to account for this possibil-
method “relects a signiicant human contribution . . . that rev- ity of continued and ongoing AI invention.
olutionized prenatal care.”32 The patent claims were generally Finally, AI may impact one of the most basic tenets of pat-
directed to detecting the presence of cell-free fetal DNA in entability because the “person of ordinary skill in the art” may
maternal plasma. Because the presence of cell-free fetal DNA no longer be a person. Claim construction, novelty, and obvi-
was a natural phenomenon, the court turned to the second ousness are all determined from the perspective of a person of
step in the Mayo/Alice framework—whether the claim con- ordinary skill in the art. With the rise of AI, the question must
tained an inventive concept suficient to transform the naturally be answered, who (or what) is that “person”? Is it the AI itself
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
that developed its own code and network? Is it the medical 19. Ramesh et al., supra note 3, at 336.
professional or experts against whom the AI is compared and 20. Id.
who prepared the initial data that was used to program the AI? 21. Id.
Is it the software and hardware developers who designed the 22. Alice Corp. Pty. Ltd. v. CLS Bank Int’l, 134 S. Ct. 2347
original AI system? The answer to these questions could well (2014); Mayo Collaborative Servs. v. Prometheus Labs., Inc., 566
determine the patentability of an invention as well as its scope. U.S. 66 (2012).
23. Mayo, 566 U.S. at 69.
Conclusion 24. Id. at 82.
As the use of AI in medicine grows ever more prevalent and 25. Id.
sophisticated, these questions will have to be answered by 26. Alice, 134 S. Ct. at 2355.
Congress, the USPTO, and the courts. The most pressing ques- 27. See, e.g., Artiicial Intelligence Sys. for Genetic Analysis,
tion to be resolved is that of subject matter eligibility, so that U.S. Patent No. 8,693,751 (iled Jan. 12, 2012); Clinical Decision-
innovation in this burgeoning ield is not stiled. The long Making Artiicial Intelligence Object Oriented Sys. & Method, U.S.
shadow cast by Mayo and Alice has already prevented the pat- Patent App. No. 14/324,396 (iled July 7, 2014); Integrated Med.
enting of “revolutionary” diagnostic technology; patent drafters Platform, U.S. Patent App. No. 15/039,419 (iled July 7, 2015);
must take care to prevent the same from occurring with AI Local Diagnostic & Remote Learning Neural Networks for Med.
inventions until this question is answered. From there, the dei- Diagnosis, U.S. Patent App. No. 00/027,220 (iled Oct. 3, 2000).
nitions of “person,” “inventor,” and “individual” will have to be 28. U.S. Patent. App. No. 15/234,814 (iled Aug. 11, 2016).
revisited, so that our understanding of inventorship and own- 29. Id.
ership evolves with this rapidly advancing technology. Early 30. Id.
recognition and resolution of these issues will allow patent law 31. Id.
to keep pace with this new “rise of the machines.” n 32. 788 F.3d 1371, 1376, 1379 (Fed. Cir. 2015).
33. Id.
Endnotes 34. Id. at 1377.
1. 1 Encyclopedia of Artificial Intelligence 54–57 (Stu- 35. Alice Corp. Pty. Ltd. v. CLS Bank Int’l, 134 S. Ct. 2347,
art C. Shapiro ed., 2d ed. 1992). 2354 (2014) (citing Mayo Collaborative Servs. v. Prometheus Labs.,
2. Alan Turing is credited as the founder of modern computer Inc., 566 U.S. 66, 71–72 (2012)).
science and AI, coining the “Turing test” to answer the question 36. Alexa Johnson, A Crisis of Patent Law and Medical Innovation:
whether machines can think. A.M. Turing, Computing Machinery The Category of Diagnostic Claims in the Wake of Ariosa v. Seque-
and Intelligence, 59 Mind 433, 433–34 (1950). nom, 27 Health Matrix 435 (2017); Patent Publius, Federal Circuit
3. A.N. Ramesh et al., Artiicial Intelligence in Medicine, 86 Threatens Innovation: Dissecting the Ariosa v. Sequenom Opinion,
Annals Royal C. Surgeons Eng. 334 (2004). Ctr. for Protection Intell. Prop. (June 23, 2015), https://cpip.gmu.
4. Id. at 335. edu/2015/06/23/federal-circuit-threatens-innovation-dissecting-the-
5. Id. sequenom-v-ariosa-opinion/; Gene Quinn, Supreme Court Denies Cert.
6. Id. in Sequenom v. Ariosa Diagnostics, IPWatchdog (June 27, 2016),
7. Id. at 335–36. http://www.ipwatchdog.com/2016/06/27/70409/id=70409/.
8. Andre Esteva et al., Dermatologist-Level Classiication of Skin 37. Ariosa, 788 F.3d at 1381 (Linn, J., concurring).
Cancer with Deep Neural Networks, 542 Nature 115 (Feb. 2, 2017). 38. 35 U.S.C. § 100(f).
9. Taylor Kubota, Deep Learning Algorithm Does as 39. New Idea Farm Equip. Corp. v. Sperry Corp., 916 F.2d 1561,
Well as Dermatologists in Identifying Skin Cancer, Stan. 1566 n.4 (Fed. Cir. 1990).
News (Jan. 25, 2017), http://news.stanford.edu/2017/01/25/ 40. Ben Hattenback & Joshua Glucoft, Patents in an Era of Ini-
artiicial-intelligence-used-identify-skin-cancer/. nite Monkeys and Artiicial Intelligence, 19 Stan. Tech. L. Rev. 32,
10. Esteva et al., supra note 8. 46 (2015).
11. Id. 41. Tony Bradley, Facebook AI Creates Its Own Language
12. Id. in Creepy Preview of Our Potential Future, Forbes (July 31,
13. Artiicial Intelligence Is on the Precipice of Revolutioniz- 2017), https://www.forbes.com/sites/tonybradley/2017/07/31/
ing Medical Diagnosis, 13D Res. (Apr. 14, 2017), https://latest.13d. facebook-ai-creates-its-own-language-in-creepy-preview-of-our-
com/artiicial-intelligence-is-on-the-precipice-of-revolutionizing- potential-future/#671deb97292c; Sam Wong, Google Translate
medical-diagnosis-be6427239f58; see also Cognoa, https://www. AI Invents Its Own Language to Translate with, New Scientist
cognoa.com/ (last visited Nov. 4, 2017); Marlena Duda et al., Clini- (Nov. 30, 2016), https://www.newscientist.com/article/2114748-
cal Evaluation of a Novel and Mobile Autism Risk Assessment, 46 J. google-translate-ai-invents-its-own-language-to-translate-with/.
Autism & Developmental Disorders 1953, 1953 (2016). 42. Toby Bond, How Artiicial Intelligence Is Set to Disrupt Our
14. Duda et al., supra note 13, at 1956. Legal Framework for Intellectual Property Rights, IPWatchdog
15. Id. at 1953. (June 18, 2017), http://www.ipwatchdog.com/2017/06/18/artiicial-
16. Ramesh et al., supra note 3, at 336. intelligence-disrupt-legal-framework-intellectual-property-rights/
17. Angela Torres & Juan J. Nieto, Fuzzy Logic in Medicine and id=84319/.
Bioinformatics, J. Biomedicine & Biotechnology (2006). 43. Hattenback & Glucoft, supra note 40, at 46.
18. Id. 44. Id.
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
The
APA in PTAB
Proceedings
Notice and an Opportunity
to Be Heard
By Daniel Zeilberger
and Michael Wolfe
Image: iStockPhoto
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
I
t is only natural that in the course of a proceeding
before the Patent Trial and Appeal Board (PTAB) a
party will think of some new argument or strategy it
wants to pursue. But what happens when the other
side to this new pursuit is not given a fair chance to
respond? The America Invents Act (AIA) brought with
it a highly regulated system of checks and balances
intended to avoid this type of problem—but sometimes
things go wrong. When they do, parties have increas-
ingly turned to the Administrative Procedure Act
(APA) and its hallmark requirement under 5 U.S.C.
§ 554(b)(3) obligating agencies to provide notice and
an opportunity to be heard.
Avoiding
Federal Circuit took note of the cuit, the court irst noted that
PTAB’s practice of allowing the PTAB treated igure 18 as
patent owners to ile a surreply an essential part of its obvious-
APA pitfalls
following a petitioner’s reply ness inding, thus rebufing any
in appropriate circumstances, claims that this igure was only
a tradition that Belden did not cited to inform the “state of the
is critical to
pursue. art.”6 The court held that in the
Therefore, the court found proceeding in which igure 18
no APA violation because the was cited in the petition, NuVa-
obtain a result
PTAB appropriately followed sive’s patent owner’s response
the statutory, regulatory, and provided the APA-required
practical framework in handling opportunity to respond. How-
that withstands
Berk-Tek’s reply declaration. ever, in the other proceeding
Belden was able to cross-exam- where igure 18 was not cited in
ine the reply declarant, submit the petition, NuVasive did not
appellate
nonargumentative observations, have a meaningful opportunity
and ile a motion to exclude the to respond. The court held that
reply declaration. Perhaps even the opportunities to cross-exam-
review.
more importantly, there were ine Medtronic’s expert and ile
multiple other avenues of relief “observations” on such cross-
that Belden could have, but did examination were an insuficient
not, pursue (discussed below). opportunity to respond under the
Thus, according to the Federal Circuit, Belden was not denied APA because Medtronic could not submit new evidence with
“a meaningful opportunity to respond” where the PTAB did the observations and such observations are limited in scope
not deny any “concrete, focused requests.”3 (and in this case were rejected as being too argumentative).
Therefore, the court vacated and remanded.
Applying the Roadmap On the other hand, Genzyme involved a failed APA chal-
Avoiding APA pitfalls can be critical to obtaining a result that lenge by a patent owner, opposing new evidence introduced
can withstand appellate review. Conversely, awareness of the with a petitioner’s reply. In Genzyme, Biomarin iled IPR
minimum threshold for an APA violation can help aggrieved petitions based on multiple prior art references, some describ-
parties avoid having their complaints fall on deaf ears. How- ing in vitro (test tube) experiments and some describing in
ever, such analysis is often nuanced. vivo (in a live organism) experiments. The PTAB only insti-
tuted review on the in vitro references. In its patent owner’s
New Argument or Evidence in a Petitioner’s Reply responses, Genzyme attacked these references as not being
Consider what may be the most common potential pitfall for predictive of results in a human patient, and simultaneously
a petitioner—a patent owner submits an unanticipated argu- argued that the in vivo references could not be relied on to
ment in its post-institution response, and the petitioner wants show obviousness because they were either part of a nonin-
to present some new argument or evidence in its reply. Is stituted ground or not relied on in the petitions. Responding
doing so ever okay? The competing results in In re NuVasive, to this argument, Biomarin, in its replies, argued that such
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
references were relevant to show the “state of the art” at the v. Volkswagen Group of America, Inc., the court held that the
time of the inventions, and cited two in vivo references (one PTAB violated the patent owner’s APA rights to notice and
of which it had asserted in its petitions as a part of a nonin- opportunity to respond by newly relying on speciic disclo-
stituted ground). The PTAB ultimately found the claims to be sures in a reference, “Stiles,” in its inal written decision in
unpatentable as obvious, and cited the two in vivo studies as order to hold unpatentable certain dependent claims.12 This
support for its indings as to the state of the art. was a notice violation even though Stiles was included in the
On appeal to the Federal Circuit, Genzyme argued that the unpatentability grounds listed in the petition, the speciic por-
PTAB violated the APA by relying on in vivo references that tion of Stiles relied on by the PTAB was block quoted in the
were not a part of the instituted grounds. The court irst held prior art background section of the petition, and the disclo-
that the introduction of new evidence in a reply is not a per se sures in Stiles were speciically applied to other claims within
violation of the APA: the same ground. The court held that the petition did not put
the patent owner on notice that Stiles would be applied to
[T]he introduction of new evidence in the course of the trial is the dependent claims at issue because the highly speciic and
to be expected in inter partes review trial proceedings and, as detailed invalidity contentions in the petition only cited a dif-
long as the opposing party is given notice of the evidence and ferent reference (Saito) as disclosing those claims’ features.
an opportunity to respond to it, the introduction of such evi- Similarly, the court held that the institution decision did not
dence is perfectly permissible under the APA.7 put the patent owner on notice because the decision only cited
Saito for those claims.
Regarding APA notice and an opportunity to respond, Of course, petitioners can also be surprised by new argu-
the court found that Genzyme not only had notice of the in ments to which they do not have an opportunity to respond.
vivo references and an opportunity to respond, but also took For instance, the Federal Circuit made clear in SAS Institute,
advantage of this opportunity when it argued against the in Inc. v. ComplementSoft, LLC—where the PTAB had intro-
vivo references in its patent owner’s response. The court fur- duced a new claim construction in its inal written decision
ther noted that Genzyme failed to ile a motion to exclude that caused it to rule against the petitioner—that the APA’s
these in vivo references and failed to ask for a surreply. protections in § 554(b)(3) apply to the petitioner just as they
Therefore, the court held that there was no APA violation. do to a patent owner.13
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
bviousness-type double patenting (ODP) is a judge-made doctrine intended
O to prevent a patentee from unfairly extending its patent term by obtaining dif-
ferent patents for essentially the same invention.1 It also facilitates common
ownership of affected patents, which helps to “prevent multiple infringement suits
by different assignees asserting essentially the same patented invention.”2 ODP
occurs where a claim in a later patent is patentably indistinct from (i.e., is either
anticipated or rendered obvious by) a claim in an earlier patent.3
Image: iStockPhoto
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
To prevent invalidation due to ODP, an applicant or The URAA altered the terms of patents issued from appli-
patentee should ile a terminal disclaimer either during exam- cations iled before June 1995 to the longer of 17 years from
ination or after patent issuance. The terminal disclaimer the issue date or 20 years from the iling date, and set the
restricts the patent’s term to the complete, statutory term of a terms of patents issued from applications iled after June
second patent.4 To obviate an ODP rejection received during 1995 to 20 years from the iling date.9 At the same time, Con-
examination or reexamination, the terminal disclaimer must gress introduced patent term adjustment (PTA), providing an
also certify that the two patents will remain under common additional patent term to make up for United States Patent
ownership throughout their enforceable lifetime.5 A terminal and Trademark Ofice (USPTO) processing delays.10 Accord-
disclaimer generally cannot be rescinded or amended.6 ingly, since 1995, US patent terms are no longer based on
Recent Federal Circuit decisions have made it increas- issue dates, and the term of a later-issued patent is not neces-
ingly challenging to avoid double patenting. In particular, two sarily longer than that of an earlier-issued patent.
related Federal Circuit appeals involving patents owned by Courts have recently considered how ODP should be
Janssen Biotech, both argued in early October 2017, and the handled in light of changes to the patent term. For exam-
earlier Federal Circuit cases on which they are based, illus- ple, Gilead Sciences, Inc. v. Natco Pharma Ltd. addressed
trate key issues that patent applicants who want to maximize whether an earlier-iled but later-issued patent can act as a
the patent term should keep in mind: the types of patents double patenting reference against an earlier-issued but later-
that can give rise to double patenting and the extent to which iled patent.11 Before 1995, a later-issued patent always had
restriction requirements during examination can protect a longer term than an earlier-issued patent because the patent
against it.7 term was linked to the issue date.12 Before the URAA, il-
ing a terminal disclaimer in an earlier-issued patent against a
Patent Term and Terminal Disclaimers, from Gilead later-issued patent had no patent term consequence. Gilead,
to Janssen however, involved two post-URAA patents with 20-year from
Traditionally, double patenting has been based on the respec- iling date terms. As a result, the earlier-issued ’483 patent
tive issue dates of two patents rather than on their respective had the longer term, as shown in igure 1.13
iling dates. Prior to June 1995 when the Uruguay Round The panel majority in Gilead found that the later-issued
Agreements Act (URAA) became effective, patent terms but earlier-iled ’375 patent could, in fact, be an ODP refer-
were 17 years from the issue date of each patent, meaning ence against the earlier-issued ’483 patent. This resulted in an
that the term of a later-issued patent was always longer than unexpected reduction in the patent term of the ’483 patent to
that of an earlier-issued patent. Typically, a court or patent that of the ’375 patent.14 The panel majority pointed out that
examiner would consider whether the claims of a later-issued in prior cases where the expiration date was tied to the issue
patent were patentably distinct from those of an earlier-issued date, issue dates were used as stand-ins for expiration dates,
patent, and if not, a terminal disclaimer could avoid invalidity but that, in this case, it did not matter which patent issued
by restricting the term of the later-issued patent to that of the irst.15 In the court’s opinion, a focus on the issue date could
earlier-issued patent.8 lead to “gamesmanship during prosecution” (e.g., arranging
‘483
‘375
1994 1996 1998 2000 2002 2004 2006 2008 2010 2012 2014 2016
Figure 1
Amelia Feulner Baur, PhD is a founding partner at McNeill Baur PLLC. She specializes in life science patent diligence and opinions,
prosecution, and world-wide portfolio management. She can be reached at amelia.baur@mcneillbaur.com. Elizabeth A. Doherty is a
partner in the California ofice of McNeill Baur PLLC, and specializes in patent prosecution and related strategic counseling, opinion, and
diligence work for life science and pharmaceutical clients. She can be reached at elizabeth.doherty@mcneillbaur.com.
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
Figure 2
for applications with later iling dates to issue irst).16 Gilead as speciically concerning patents that do not stem
In AbbVie Inc. v. Mathilda & Terrence Kennedy Institute of from a common application, but instead were purposely iled
Rheumatology Trust, the Federal Circuit afirmed that a later- at different times and with different priority dates.24
issued patent can be a double patenting reference against In view of these cases, applicants should take care in struc-
an earlier-issued patent.17 A related question not specii- turing claims among related patent applications, particularly
cally addressed in Gilead or AbbVie is whether this reasoning if one or more applications achieve a signiicant PTA award.
applies to patents having the same effective iling dates, such We discuss this in more detail below.
as a parent and a continuation application where the differ-
ence in term is solely due to a PTA award and not due to any What Is a Divisional Application under 35 U.S.C.
“gamesmanship” by the applicant. The US District Court for § 121 Safe Harbor?
the Western District of Michigan has applied Gilead to this A further question in Janssen is whether Janssen’s ’471
situation, effectively wiping away a 418-day PTA award in patent is also invalid for ODP over two other later-issued
a parent patent due to issuance of a child patent with similar patents, both of which are continuations-in-part (CIPs) in
claims.18 relation to the ’471 patent (see ig. 3). Janssen has argued that
The Federal Circuit is analyzing the scope of Gilead in the ’471 patent is protected by the safe harbor of 35 U.S.C.
Janssen Biotech, Inc. v. Celltrion Healthcare Co.19 The ques- § 121, which protects parent and divisional applications
tion in Janssen, as depicted in igure 2, is whether ODP whose claims were separated due to a restriction requirement
restricts the term of an earlier-issued but later-expiring pat- from indings of ODP over each other. The policy behind
ent in the same family, where the earlier-issued patent was
iled before the URAA took effect.20 Not only do the terms of
the ’471 and ’444 patents differ due to the URAA, but, unlike
the Gilead patents, they also originate from the same priority ‘413 Application
application. Thus, this case allows the Federal Circuit to con-
sider whether Gilead should apply to pre- and post-URAA CIP CIP
patents as well as to patents in the same application family,
whose terms differ due to a change in law.
The district court in Janssen found that ODP applies to
this situation such that the earlier-issued ’471 patent is now
expired in view of the later-issued ’444 patent, noting that ‘471 patent ‘272 patent
Janssen “decided to take at least the risk that the ’471 [patent]
would be deemed invalid when the ’444 [patent] expired.”21
On appeal, Janssen argues that the two patent terms differ
merely due to changes in law, not because of the “games- CIP
manship” Gilead sought to prohibit.22 According to Janssen,
Congress did not intend to alter the existing ODP doctrine
when enacting the URAA, and the district court’s decision
accordingly “departs from the well-established rule for pre-
URAA patents that ‘“[a]ll proper double patenting rejections
. . . rest on the fact that a patent has been issued and later ‘195 patent
issuance of a second patent will continue [patent] protection,
beyond the expiration of the irst patent’ on the same inven-
tion or an obvious variation thereof.”23 Janssen distinguishes Figure 3
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
the § 121 safe harbor is to avoid penalizing a patentee with the court in Pizer noted that, to obtain the § 121 safe harbor,
an ODP rejection when the USPTO required the patentee to a patent applicant must also “maintain the line of demarca-
divide its original claims. tion between the independent and distinct inventions that
Both the district court and the USPTO’s Patent Trial and prompted the restriction requirement.”35 In other words, the
Appeal Board (PTAB), following a reexamination of the ’471 claims must remain consonant with the restriction, and an
patent, found that Janssen’s ’471 patent does not qualify for applicant should not “amend[] the claims in the divisional
the § 121 safe harbor because the ’471 patent is not a “true” application in a way that would violate the originally imposed
divisional application as deined in § 121.25 restriction requirement” because that would “impermissibly
Janssen had, in its ’413 application, received a restriction extend the patent term as to that subject matter.”36
requirement separating composition and method-of-use claims. Subsequently, the Federal Circuit in Amgen Inc. v. F. Hoff-
Janssen pursued the composition claims in the application lead- man-La Roche Ltd. held that the § 121 safe harbor did not
ing to the ’471 patent, iled as a CIP of the ’413 application. Then apply to an application designated as a continuation.37
Janssen pursued the method-of-use claims in applications leading In its appeals against the USPTO and district court rulings,
to the ’272 and ’195 patents, iled as CIPs of the ’413 application Janssen contends that, unlike in Pizer and Amgen, Janssen had
and the application leading to the ’471 patent, respectively.26 speciically advised the USPTO that the application leading to
Janssen argues on appeal that the § 121 safe harbor applies the ’471 patent was iled in response to the earlier restriction,
to these patents because, even though they are CIPs in name, that its claims did not rely on the subject matter added in the
they are divisionals in operation.27 Speciically, says Janssen, CIP, and that its claims maintained consonance with the restric-
(1) the USPTO issued a restriction requiring multiple appli- tion.38 Thus, Janssen argues that the ’471 patent is a divisional
cations, (2) the claims of the applications were amended to of the ’413 application in operation even if not in name.39
be consonant with the restriction, (3) Janssen advised the Janssen also distinguishes G.D. Searle LLC v. Lupin
www.ambar.org/iplbooks
These titles available at
www.bna.com/bnabooks/abaip
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
Preserving
Provisional
Rights for
Pre-Issuance
Patent
Damages
A
rarely invoked but potentially powerful damages
By Brian V. Slater and John P. Dillon remedy can arise for infringing acts before a pat-
ent issues. Generally, patent owners may collect
damages only for infringement after patent issu-
ance.1 However, 35 U.S.C. § 154(d) provides
that a patentee may, under certain circumstances,
obtain a retroactive reasonable royalty from an infringer hav-
ing actual notice of a published patent application. This
remedy––called “provisional rights”––dates back to the 1999
congressional amendments to the Patent Act that, among other
things, brought the US patent system more in line with patent
application standards in the rest of the world.2 Those amend-
ments included the requirement that most patent applications
be published 18 months after their iling. In exchange for this
early publication, and in view of the risk of third parties gain-
ing a competitive advantage from that information, Congress
provided patentees with a reasonable royalty remedy against
any third-party infringer who uses the claimed invention during
the period beginning on the date of patent application publi-
cation and ending on the date the patent issues, provided that
(1) the third party had “actual notice” of the published pat-
ent application, and (2) the invention as claimed in both the
published patent application and the issued patent is “substan-
tially identical.”3 This article discusses recent Federal Circuit
interpretation of these two requirements, identiies some open
issues under § 154(d), and offers guidance to practitioners on
preserving this potentially valuable remedy.
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
“Actual Notice” Requirement that knowledge of the published patent application is not
For provisional rights to arise, § 154(d) requires that the suficient and that there must be an afirmative act by the
infringing party “had actual notice of the published pat- applicant to put the alleged infringing party on notice.15
ent application.”4 For several years after passage of the 1999 In an issue of irst impression, the Federal Circuit held that
amendments, parties litigated the boundaries of what consti- constructive notice of the published patent application is not
tutes “actual notice,” including whether constructive notice is suficient and “actual knowledge” is required. In addition, the
suficient and whether there is a requirement of an afirmative Federal Circuit rejected Adobe’s proposed heightened standard,
act on the part of the patentee as there is for patent marking holding that while “actual notice” includes an applicant afirma-
under 35 U.S.C. § 287. In 2016, the Federal Circuit clari- tively acting to provide the infringer with notice of the published
ied both issues when it ruled on the scope and meaning of application, an afirmative act by the applicant is not required.
§ 154(d)’s “actual notice” requirement in Rosebud LMS Inc. The Federal Circuit reached this decision by construing the ordi-
v. Adobe Systems Inc. (Rosebud III).5 nary meaning of “actual notice” to include “knowledge obtained
without an afirmative act of notiication.”16 In so holding, the
Background of Rosebud court refused to import into § 154(d) the afirmative act require-
Rosebud III was the third in a series of infringement lawsuits ment from the patent marking statute.17
brought by the patentee Rosebud against Adobe. Rosebud’s On the merits, the Federal Circuit afirmed, agreeing
irst lawsuit alleged infringement of US Patent No. 7,454,760 with Adobe that Rosebud did not raise a genuine issue of
(’760 patent), and was both iled and dismissed in 2010 (Rose- material fact. First, the Federal Circuit rejected Rosebud’s
bud I).6 Rosebud’s second lawsuit involved US Patent No. argument that knowledge of the grandparent patent (the
8,046,699 (’699 patent), and was iled in 2012 and dismissed ’760 patent) necessarily rose to knowledge of the claims of
in February 2014 (Rosebud II).7 Rosebud’s third and presently the grandchild patent application, and not merely a shared
discussed lawsuit involved US Patent No. 8,578,280 (’280 pat- speciication. Because knowledge of related patents does
ent), and was brought shortly before dismissal of Rosebud II, not identify the scope of the claimed invention, the court
in February 2014. Important to this discussion, all three patents held that such knowledge is “legally insuficient to establish
at issue in these cases were part of the same family of patent actual notice of the published patent application.”18 Second,
applications and shared the same speciication. the Federal Circuit held that Rosebud’s evidence allegedly
Adobe moved for summary judgment that Rosebud was showing Adobe followed and emulated Rosebud’s products
not entitled to, among other things, a reasonable royalty did no such thing—rather, the “evidence” consisted only of
under § 154(d), because Adobe had no actual notice of the seven e-mails sent more than two years prior the ’280 patent
published patent application that issued as the ’280 patent. application publication.19 Last, the Federal Circuit rejected
In opposing Adobe’s motion for summary judgment, Rose- Rosebud’s argument that Adobe’s Rosebud II outside counsel
bud sought to establish a genuine issue of material fact as to would have detected the ’280 patent application publication
Adobe’s actual knowledge of the publication of the applica- in evaluating claim construction arguments, observing that
tion for the ’280 patent. First, Rosebud argued that Adobe “Rosebud II never reached the claim construction stage.”20
had actual knowledge of the grandparent to the ’280 patent,
i.e., the ’760 patent.8 Second, Rosebud argued that Adobe “Substantially Identical” Requirement
“followed Rosebud and its product and sought to emulate In addition to establishing infringement and proving that the
some of its product’s features.”9 Third, Rosebud argued that it infringer had actual notice, the patentee must show that the
would have been standard practice in the industry for Adobe’s invention as claimed in the issued patent is “substantially
outside counsel in Rosebud II to search for the ’280 patent identical” to the invention as claimed in the published patent
application, which was published before Rosebud II was iled application.21 The scope of this provision was the subject of
and related to the patent asserted in that suit.10 It was undis- the Federal Circuit’s nonprecedential opinion in Innovention
puted that Rosebud did not afirmatively give Adobe notice of Toys, LLC v. MGA Entertainment, Inc.22
the published ’280 patent application.11 The patent at issue in Innovention Toys was directed to a
Judge Sue Robinson of the District of Delaware granted Ado- “chess-like board game and methods for playing the game.”23
be’s motion for summary judgment, holding that Rosebud had The board game “generates laser beams for the players, who
not satisied § 154(d)’s requirement of actual notice because have various movable board pieces,” and the “players ‘alter-
Rosebud’s evidence was, at best, evidence of constructive nate in moving pieces from square to square or rotating pieces
notice.12 The district court also rejected the argument that Adobe,
based on its litigation history with Rosebud, had an afirmative Brian V. Slater, chair of the life sciences practice, is a irst-chair trial
duty to search for Rosebud’s published patent applications.13 lawyer with over 25 years of patent litigation experience. Mr. Slater
leads trial teams in high-stakes pharmaceutical and biotechnology
The Federal Circuit’s Decision patent litigation before both the district courts and the Patent Trial
On appeal to the Federal Circuit, Rosebud argued that there and Appeal Board. John P. Dillon works on complex pharmaceutical
was suficient circumstantial evidence of Adobe’s knowl- patent litigation, including litigation arising under the Hatch-Waxman
edge of the published patent application for the ’280 patent Act. Mr. Dillon’s work involves all aspects of patent litigation: pre-suit
that a reasonable jury could ind in its favor.14 Adobe, in investigation of infringement and invalidity issues, drafting dispositive
turn, argued, based on the legislative history of § 154(d), motions, preparing expert witnesses, and managing discovery.
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
Entitlement to substantive changes have been made [to a published patent appli-
cation’s claim], we must discern whether the scope of the claims
are identical, not merely whether different words are used.”29
provisional rights In determining that the issued claims and the published
patent application claims were of the same scope, the court
rejected MGA’s arguments that (1) the published applica-
tion claims did not require an element of “movability of key
requires proof of pieces,” and (2) claim amendments that changed the transi-
tional phrase “consisting of” to “comprising” broadened the
scope of some of the claims. Regarding MGA’s irst argu-
actual knowledge ment, the Federal Circuit found that, contrary to MGA’s
assertions, the published application’s claims did contain
an element requiring movability of key pieces––the pub-
patent application, to infringe here retain their original scope, and MGA has not
contended that any of the infringing acts here infringed only
the broadened claims.”31 On that basis, the Federal Circuit
not merely
afirmed the jury award of provisional rights damages.
evidence.
As noted above, the Federal Circuit in Rosebud III held that
“actual notice” means “knowledge obtained without an afirmative
act of notiication,” but Rosebud III stops short of explaining what
level of “knowledge” is required or how to prove it. For example,
in place.’”24 The purpose of such movement or rotation is to Rosebud III does not address whether the accused infringer merely
relect and change the direction of the laser beams (an ability needs to be in possession of the published patent application or
of certain pieces that have mirrors), with an end goal to “direct instead must have some knowledge of how the claims of the pub-
his or her laser onto the opposing side’s ‘key piece.’”25 The pat- lished application relate to a speciic product or activity. While
ent’s earliest priority date was February 2005. the statute speaks of “actual notice of the published patent appli-
Innovention exhibited a prototype of its embodiment, cation,” some may argue that the statute would have no deterrent
Delexion, at a toy fair in New York City in early 2005. An effect if an accused infringer has no knowledge of how the claims
MGA game developer who attended the fair, Ami Shap- of the application might apply to a speciic product or activity.32
iro, began working on a competing board game titled “Laser On the other hand, requiring too high a level of knowledge may
Battle.” In December 2005, Shapiro bought two copies of encourage a head-in-the-sand approach by infringers. For now, the
Delexion, which were marked “patent pending,” and sent exact level of knowledge required and how to prove it remain to be
one of them to another MGA engineer. Innovention’s patent leshed out in future court decisions.
application published in October 2006, and when Innoven-
tion learned of Laser Battle in late 2006, it sent MGA a notice When Do Provisional Rights Damages Begin?
letter with a copy of the published application.26 Following Another question is whether the § 154(d) reasonable royalty
certain amendments to the claims, the patent issued in Sep- runs from the date that the patent application is published or
tember 2007, and Innovention brought suit.27 only from the date upon which the infringer obtains actual
The district court granted summary judgment of infringe- notice of the publication. The statute states that a patentee is
ment, and a jury awarded to Innovention, among other things, entitled to damages for infringement “during the period begin-
provisional rights damages. MGA appealed the jury’s award. ning on the date of publication of the application” and “ending
On appeal to the Federal Circuit, the court held that issued on the date the patent is issued,” apparently without regard to
claim 31 was a representative claim and was directed to a “game the date on which the infringer obtained actual notice.33 Some
board, movable playing pieces having at least one mirrored sur- may argue the requirement that the infringer have “actual
face, movable key playing pieces having no mirrored surfaces, and notice” does not alter the statute’s language that a patentee can
a laser source.”28 Turning to the issue of provisional rights dam- receive damages dating back to the “date of publication.” Oth-
ages, and borrowing from case law developed under the patent ers, however, may argue that it would be unduly punitive and
reissue statute, the court explained that “in determining whether serve no deterrent effect to award a reasonable royalty before
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
the infringer had actual notice of the claims. Again, it remains rights, and so practitioners should consider requesting
to be seen how courts will address this issue. republication under such circumstances and repeating the
suggested steps identiied above.
Do Republished Applications Give Rise to Provisional Rights?
The United States Patent and Trademark Ofice’s (USPTO’s) rules Conclusion
permit an applicant to seek republication of its patent application Section 154(d) remains a viable tool for patentees to increase
during prosecution.34 The question arises whether a republished the damages they are entitled to for infringement, and prac-
patent application can give rise to provisional rights, assuming its titioners would be well advised to preserve this remedy by
claims are substantially identical to those of the issued patent. promptly putting accused infringers on notice of published
Section 154(d) does not speciically address republica- patent applications. n
tion of patent applications, and because there are no cases
addressing this issue, a republished application’s ability to Endnotes
confer provisional rights is an open question. One commen- 1. 35 U.S.C. § 271.
tator suggests that it “seems likely that [the courts] would 2. American Inventors Protection Act of 1999, Pub. L. No. 106-
interpret republished claims the same way as originally pub- 113, app. I, tit. IV, 113 Stat. 1501, 1501A-552 to -591.
lished claims, albeit with different effective dates of notice.”35 3. 35 U.S.C. § 154(d). Section 154(d)(3) places a statute of limita-
To that end, it is notable that § 154(d) requires that US pat- tions on a patentee seeking a reasonable royalty. An infringement action
ent applications be published “under section 122(b).” Section must be brought no later than six years after the date the patent issues.
122(b) states that “each application for a patent shall be pub- 4. Id. § 154(d)(1)(B).
lished, in accordance with procedures determined by the 5. 812 F.3d 1070 (Fed. Cir. 2016).
Director.”36 Because the USPTO’s rules provide for repub- 6. Id. at 1072.
lication of patent applications, there is an argument that 7. Id.
provisional rights should apply to republished patent appli- 8. Id.
cations. On the other hand, § 122(b) refers to publication 9. Id.
“promptly after the expiration of a period of 18 months from 10. Id. at 1072–73.
the earliest iling date for which a beneit is sought,” so some 11. Id. at 1073.
may argue that provisional rights do not apply to any republi- 12. Id. at 1075.
cation of the application outside of that time window. 13. Id. at 1073.
14. Id. at 1075.
Practice Tips 15. Id. at 1074.
The main takeaway from Rosebud III is that entitlement to 16. Id.
provisional rights requires proof of actual knowledge of a 17. See 35 U.S.C. § 287(a).
published patent application, not merely circumstantial evi- 18. Rosebud III, 812 F.3d at 1075.
dence. And although an afirmative act by the patentee is not 19. Id.
necessary, practitioners would be well advised to put sus- 20. Id. at 1076.
pected infringers “on notice,” and preserve the ability to seek 21. 35 U.S.C. § 154(d)(2).
a reasonable royalty, by following these suggested steps: 22. 611 F. App’x 693 (Fed. Cir. 2015) (nonprecedential), vacated
• Deliver to oficers of the accused infringer a letter on other grounds, 136 S. Ct. 2483 (2016).
enclosing a copy of the published patent application, 23. Id. at 695.
using a courier that provides a signature receipt. 24. Id.
• If the published patent application is international des- 25. Id.
ignating the United States and is not in English, provide 26. Id. at 696.
an English translation.37 27. Id.
• Consider identifying in the letter the allegedly infring- 28. Id. at 695.
ing acts and exemplary published claims that would be 29. Id. at 699 (quoting Laitram Corp. v. NEC Corp., 163 F.3d
infringed. While this identiication may not be required 1342, 1346 (Fed. Cir. 1998)).
under Rosebud III, including it in the letter may head off an 30. Innovention Toys, 611 F. App’x at 699.
argument that the accused infringer had no “knowledge.” 31. Id. at 700.
• Retain a copy of the notice and conirmation of the mail 32. 35 U.S.C. § 154(d)(1)(B).
delivery. 33. Id. § 154(d)(1).
Additionally, based on Innovention Toys, practitioners 34. U.S. Patent & Trademark Office, Manual of Patent Exam-
should carefully consider the impact of any amendments dur- ining Procedure (MPEP) § 1130 (9th ed. Rev. 07.2015, Nov. 2015).
ing prosecution on any possible provisional rights remedy. 35. Kevin King et al., Maximizing Patent Damages: Provisional
While small amendments that merely “clarify” claim lan- Rights and Marking, Law360 (July 18, 2017), https://
guage may preserve provisional rights, amendments that wwwww.law360.com/articles/942436/
arguably change the “scope” of the claim will jeopardize such maximizing-patent-damages-provisional-rights-and-marking.
rights. As discussed above, republishing a patent application 36. 35 U.S.C. § 122(b)(1)(A).
after claims have been amended may give rise to provisional 37. See id. § 154(d)(1)(B).
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
Decisions in Brief
By John C. Gatz
COPYRIGHTS
Dating Book’s Copyright Not Infringed YouTube Video Critical of Another Video Is Fair Use
Parker v. PayPal, Inc., 2017 U.S. Dist. LEXIS 130800, 2017 Hosseinzadeh v. Klein, Inc., 2017 U.S. Dist. LEXIS 134910,
WL 3508759 (E.D. P.A. 2017). Parker wrote and published 2017 WL 3668846 (S.D.N.Y. 2017). Matt Hosseinzadeh
a dating advice book. This book was later sold as part of a created several YouTube videos featuring a character he cre-
compilation of dating advice articles on a website. Parker ated, “Bold Guy.” In these videos, Bold Guy generally hits
sued a number of entities including Amazon for copyright on women in a variety of different settings. Ethan and Hila
infringement, unfair competition under the Lanham Act, Klein are also YouTube personalities, and they posted a video
misappropriation of likeness, breach of contract, and unjust that was critical of one of Hosseinzadeh’s videos, “Bold Guy
enrichment. Amazon moved to be dismissed from the case. vs. Parkour Girl.” In their critique, the Kleins interspersed
The court granted Amazon’s motion to dismiss. The dis- clips from the Hosseinzadeh video with clips of themselves
trict court found that Parker failed to state a claim for copyright criticizing and generally making fun of Bold Guy and his
infringement against Amazon as an internet service provider for attempted wooing of Parkour Girl. Hosseinzadeh submitted a
hosting the unauthorized copies of his book. The district court DMCA takedown notiication to YouTube, the Kleins submit-
cited a Fourth Circuit case that found hosting content is like ted a counter-takedown notiication, and Hosseinzadeh sued
owning a copying machine that the public may access where the the Kleins for copyright infringement, for misrepresentation
owner does not actually copy the materials. The district court in their counter-takedown notice, and for defamation.
found the passive act of hosting copyrighted material is not The district court sided entirely with the Kleins, inding
direct copyright infringement, contributory or vicarious copy- that their use of the video was fair use and that their video
right infringement. Additionally, the district court found that the did not in any way replace the market for the original video.
Copyright Act preempted any state law breach of contract claim The criticism and commentary of the Kleins’ video weighed
against Amazon for hosting an infringing version of Parker’s heavily in favor of a inding of fair use. As for the defamation
work on their servers, as that conduct is the same conduct that claim, the district court determined that Kleins’ statements
Parker alleged showed copyright infringement. Therefore, the were clearly statements of opinion or otherwise non-action-
contract claim is equivalent to an exclusive right granted by the able. The Kleins’ motion for summary judgment was granted
Copyright Act, and is preempted by the Copyright Act. in its entirety.
PATENTS
Appealability/Covered Business Method Review/ about the biosimilar and the process used to manufacture it. The
Patentable Subject Matter sponsor is then required to provide the applicant with a list of
Return Mail, Inc. v. U.S. Postal Service, 868 F.3d 1350, 123 patents the sponsor believes the applicant may be infringing;
U.S.P.Q.2d 1813 (Fed. Cir. 2017). The Federal Circuit found only those identiied patents can form the basis of a subsequent
that it had authority to review the PTAB’s determination that lawsuit. The sponsor, Amgen, provided a patent list that did not
the petitioner had standing under AIA in a review of a cov- include any patents relating to the cell-culture medium used to
ered business method (CBM) patent. The Federal Circuit then create these types of drugs, arguing that it could not reasonably
held that the United States Postal Service had standing within identify such potentially infringed patents because the appli-
the meaning of AIA §18 because it was sued for infringement cant failed to provide suficient disclosure of the processes it
in the US Federal Court of Federal Claims. As to the merits, used. During litigation, Amgen sought to compel discovery on
the Federal Circuit held that the claims were directed to the the Applicant’s cell-culture medium. The district court denied
abstract idea of relaying mailing address data. Amgen’s motion, inding that because Amgen did not assert its
process patents, the information it sought was not relevant. The
Appellate Jurisdiction/ BPCIA Federal Circuit agreed. Accordingly, the Federal Circuit declined
Amgen Inc. v. Hospira, Inc., 866 F.3d 1355, 123 U.S.P.Q.2d to apply the collateral order doctrine. The Federal Circuit also
1697 (Fed. Cir. 2017). The Federal Circuit held that the collat- denied mandamus based on its indings that Amgen misinter-
eral order doctrine did not provide appellate jurisdiction over the preted the BPCIA. Speciically, the Federal Circuit Court found
district court’s denial of a motion to compel, and further denied that Amgen could have identiied the cell-culture medium pat-
Amgen’s mandamus request on the same. The Biologics Price ents. Amgen argued that it could not have asserted those patents
Competition and Innovation Act (BPCIA) provides details on the for fear of sanctions under Rule 11. The Federal Circuit held
information exchange that is to occur and the timing for those there would be no sanctions under the facts of this case.
exchanges with respect to possible litigation relating to biologi-
cal products. In the irst phase of the exchange, an applicant Attorney Fees
seeking an abbreviated approval from the FDA of its biosimilar AIA Am., Inc. v. Avid Radiopharmaceuticals, 866 F.3d 1369,
drug is required to provide the patent holder of the already- 123 U.S.P.Q.2d 1703 (Fed. Cir. 2017). The Federal Circuit
approved biologic drug (referred to as a “sponsor”) information afirmed the district court’s award of attorney fees under 35
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
U.S.C. § 285 against AIA. The Federal Circuit addressed Inequitable Conduct
and dismissed the three reasons presented by AIA as to why Regeneron Pharm., Inc. v. Merus N.V., 864 F.3d 1343, 123
the district court’s award of attorney fees—not the amount U.S.P.Q.2d 1469 (Fed. Cir. 2017). The Federal Circuit found
awarded—was improper. The Federal Circuit disagreed that that the district court did not abuse its discretion in holding
AIA was entitled to a jury trial under the Seventh Amendment that the patent was unenforceable due to inequitable con-
to determine whether attorney fees should be awarded. The dis- duct. The Federal Circuit irst afirmed the district court’s
trict court did not err by making factual indings about AIA’s inding that four withheld references during prosecution
state of mind, intent, and culpability. AIA also unsuccessfully were “but-for material” and not cumulative individually or in
argued that its due process rights were violated because the dis- combination. The Federal Circuit then afirmed the district
trict court did not give AIA the opportunity to submit evidence court’s decision to draw an adverse interest of speciic intent
regarding its intent, state of mind, or culpability. to deceive the PTO based on the patentee’s litigation miscon-
duct, which included discovery abuse. The Federal Circuit
Claim Construction reasoned that the patentee’s discovery abuse directly related
In re CSB-System Int’l, Inc., 832 F.3d 1335, 123 U.S.P.Q.2d to the prosecuting attorneys’ mental impressions of the mate-
1684 (Fed. Cir. 2016). The Federal Circuit afirmed the PTAB’s rial references during prosecution.
rejection of all the claims as unpatentable over the prior art
during an ex parte reexamination. First, the Federal Circuit Invalidity
determined that the PTAB erred by applying the broadest rea- Gold Standard Instruments, LLC v. US Endodontics, LLC,
sonable interpretation (BRI) standard to the claims because, 123 U.S.P.Q.2d 1711 (Fed. Cir. 2017). The Federal Circuit
although the patent was alive during the examiner’s review, afirmed an invalidity inding by the PTAB in an inter partes
it had expired before the PTAB considered it. Therefore, the review. The only issue substantively addressed by the Federal
PTAB should have applied the Phillips claim construction stan- Circuit was whether a prior art reference taught away. The
dard. The Federal Circuit found that the erroneous applied BRI Federal Circuit found that substantial evidence (expert testi-
standard did not produce a different result than what would mony) existed for the PTAB’s decision.
have been reached under the Phillips standard.
IPR
Evidence Homeland Housewares, LLC v. Whirlpool Corp., 865 F.3d
Ultratec, Inc. v. CaptionCall, LLC, 123 U.S.P.Q.2d 1793 (Fed. 1372, 123 U.S.P.Q.2d 1584 (Fed. Cir. 2017). The Federal Cir-
Cir. 2017). The Federal Circuit vacated and remanded the deci- cuit reversed the PTAB’s decision inding the claims not invalid
sion of the PTAB inding all claims either anticipated or obvious. as anticipated. The Federal Circuit found that the PTAB erred in
The Federal Circuit found that during the inter partes review, that it did not construe the term “settling speed” despite the par-
the PTAB failed to consider material evidence and failed to ties disagreeing as to the term’s construction. After construing
explain its decisions to exclude the evidence. The PTAB abused the term, the Federal Circuit found that the PTAB erred in hold-
its discretion when it failed to admit and consider expert trial tes- ing the prior art did not anticipate the claims.
timony and when it refused to explain its decision. Because the Personal Audio, LLC v. Electronic Frontier Found., 867
PTAB relied on the expert’s credibility in every IPR, the Federal F.3d 1246, 123 U.S.P.Q.2d 1592 (Fed. Cir. 2017). The Fed-
Circuit vacated every decision, and remanded for the PTAB to eral Circuit afirmed the PTAB’s decision inding the claims
admit and consider the expert’s testimony. If the PTAB inds that invalid as anticipated and/or obvious.
he gave inconsistent testimony, the Federal Circuit instructed the Soft Gel Techs., Inc. v. Jarrow Formulas, Inc., 864 F.3d 1334,
PTAB to consider the impact on the patents in the trial testimony 123 U.S.P.Q.2d 1419 (Fed. Cir. 2017). The Federal Circuit
as well as on the expert’s credibility as a whole. afirmed the PTAB’s decision inding the claims invalid as
anticipated and/or obvious. The Federal Circuit agreed with
Federal Appellate Jurisdiction the PTAB’s inding that the D-limonene is the main constitu-
Alfred E. Mann Found. for Scientiic Research v. Cochlear ent of lemon oil as it was the main ingredient in 19 different
Corp., 841 F.3d 1334, 123 U.S.P.Q.2d 1669 (Fed. Cir. 2016). samples (even where it was less than 50% of the sample, the
The Federal Circuit addressed several issues related to pat- amount was still more than any other ingredient). The prior art
ents for cochlear implants. The Federal Circuit afirmed the reference did not teach away from using lemon oil, but instead
district court’s inding that Cochlear infringed a claim. The differentiated between essential oils and other solvents. Based on
Federal Circuit afirmed an indeiniteness inding for two these two factors, the Federal Circuit found that one of ordinary
means-plus-function limitations. The Federal Circuit vacated skill in the art would be motivated to combine references disclos-
the district court’s JMOL of no willful infringement based ing using D-limonene with the other prior art.
on the Supreme Court’s decision in Halo Electronics Inc. v.
Pulse Electronics Inc. The Federal Circuit refused to address Obviousness
Mann’s argument that the district court abused its discretion Honeywell Int’l Inc. v. Mexichem Amanco Holding S.A. de C.V.,
by granting a new trial on damages. The Federal Circuit indi- 865 F.3d 1348, 123 U.S.P.Q.2d 1605 (Fed. Cir. 2017). The Fed-
cated that it lacked the jurisdiction because the district court’s eral Circuit vacated and remanded the PTAB’s afirmation of the
damages position lacked inality under both 28 U.S.C. § 1292 examiner’s rejection of claims as obvious over the prior art. The
and Federal Rule of Civil Procedure Rule 54(b). Federal Circuit found the PTAB’s obviousness analysis lawed.
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
The PTAB committed legal error by improperly relying on Visual Memory’s patent is directed to a computer memory sys-
inherency to ind obviousness and in its analysis of motivation tem having programmable operational characteristics that can
to combine references. What is important regarding properties be tailored for use with multiple different processors without
that may be inherent, but known, is whether they are unexpected. reducing system performance. The Federal Circuit found that the
The PTAB, in dismissing properties of the claimed invention as claimed subject matter was not directed to an abstract idea under
merely inherent, without further consideration as to unpredict- step one of the Alice test, but instead to an improvement to com-
ability and unexpectedness, erred as a matter of law. puter memory systems. As such, the Federal Circuit found no
In re Stepan Co., 868 F.3d 1342, 123 U.S.P.Q.2d 1838 need to address step two of the Alice test and remanded the case
(Fed. Cir. 2017). The Federal Circuit reversed the PTAB’s to the district court for further proceedings.
decision afirming the examiner’s rejection of the claims as
obvious. The Federal Circuit found that the PTAB failed to Preamble
adequately articulate its reasoning, erroneously rejected rel- Georgetown Rail Equip. Co. v. Holland LP, 867 F.3d 1229,
evant evidence of nonobviousness, and improperly shifted the 123 U.S.P.Q.2d 1766 (Fed. Cir. 2017). The Federal Circuit
burden to the applicant to prove patentability. afirmed the inding of infringement, the claim construction,
approval of the award of lost proits, and enhanced damages.
Patent Eligibility Under § 101 The district court held that the preamble was not a claim
Visual Memory, LLC v. NVIDIA Corp., 867 F.3d 1253, 123 limitation. The Federal Circuit agreed, and found that in the
U.S.P.Q.2d 1712 (Fed. Cir. 2017). The Federal Circuit reversed context of the entire patent, it was apparent that the disputed
the district court’s dismissal of Visual Memory’s patent infringe- preamble term was meant to describe the principal intended
ment complaint for failure to state a claim under Rule 12(b)(6). use of the invention, but not to import a structural limitation.
TRADE SECRETS
Opus Fund Servs. United States (USA) LLC v. Theorem Fund Stockade Cos. v. Kelly Rest. Group, 2017 U.S. Dist. LEXIS
Servs., LLC, 2017 U.S. Dist. LEXIS 160649, 2017 WL 4340123 170944, 2017 WL 4640443 (D. Tex. 2017). Stockade argued,
(N.D. Ill. 2017). The defendants moved to dismiss the Opus’s under Texas law, that its “buffet system” consisting of a laun-
trade secret misappropriation claims because all of the allega- dry list of items including recipes, manuals, training materials,
tions of misappropriation of trade secrets occurred before the trademarks, trade dress, marketing program, purchasing
enactment of the DTSA on May 11, 2016. The DTSA provides system, point-of-sale system, and gift-card system was col-
a civil remedy and there can be a partial recovery for misappro- lectively a trade secret. The district court denied the plaintiff’s
priation when some act of misappropriation occurs after May 11, request for an injunction because even assuming that this inde-
2016. However, based on the allegations in the plaintiff’s com- terminate laundry list of elements comprises trade secrets,
plaint, Opus appears to be proceeding on an acquisition theory Stockade must still prove a breach of a conidential relationship
rather than a disclosure theory of misappropriation. The allega- or discovery of the claimed trade secrets by improper means.
tions are insuficient to put the defendants on notice of disclosure Thus, the injunction was denied.
or use of the trade secrets after May 11, 2016.
TRADEMARKS
Attorneys’ Fees/Lanham Act and that the Octane Fitness standard applied to the Lanham
Romag Fasteners, Inc. v. Fossil, Inc., 866 F.3d 1330, 123 Act. The Federal Circuit noted that since Octane Fitness was
U.S.P.Q.2d 1629 (Fed. Cir. 2017). The Federal Circuit decided, the Third, Fourth, Fifth, Sixth, and Ninth Circuits
vacated the district court’s decision denying the plaintiff’s had determined that Octane Fitness deined “exceptional” for
(Romag Fasteners) request for attorneys’ fees under the Lan- fee provisions for the Patent Act as well as the Lanham Act.
ham Act. The plaintiff prevailed on claims for patent and The Federal Circuit remanded the case to the district court for
trademark infringement and was awarded attorneys’ fees further proceedings.
under the Patent Act, but not under the Lanham Act. The
district court applied the prevailing Second Circuit prece- Descriptiveness
dent under Louis Vuitton Malletier S.A. v. LY USA, Inc. and In re N.C. Lottery, 866 F.3d 1363, 123 U.S.P.Q.2d 1707 (Fed.
determined that the case was not exceptional under the Lan- Cir. 2017). The appellant N.C. Lottery appealed a decision
ham Act in the absence of bad faith, fraud, or willfulness on refusing to register its FIRST TUESDAY mark on the ground
the part of the defendants. Thus, while the case was excep- that the proposed mark is merely descriptive of the appel-
tional under the Patent Act standard of Octane Fitness, LLC lant’s goods and services. The Federal Circuit afirmed. N.C.
v. ICON Health & Fitness, Inc., the defendant had not acted Lottery sought to register the mark FIRST TUESDAY for
fraudulently or in bad faith under the Louis Vuitton standard. “lottery cards; scratch cards for playing lottery games” and
The Federal Circuit concluded that the district court erred for “lottery services.” N.C. Lottery submitted specimens,
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
including promotional materials, having explanatory text such marks to overcome the likelihood of confusion. The Federal Cir-
as “[n]ew scratch-offs the irst Tuesday of every month.” The cuit also found that Symbolic’s limited evidence of third-party
examining attorney refused registration, inding that the mark uses of I AM for the same or similar goods fell short of ubiqui-
was merely descriptive. The TTAB afirmed. tous or considerable uses of the mark. Thus, the Federal Circuit
The Federal Circuit disagreed with N.C. Lottery’s argument afirmed the TTAB’s decision to refuse registration.
that any explanatory text in specimens cannot supply addi-
tional meaning to a mark when the mark itself does not convey Primarily Merely a Surname
that meaning. Explanatory text should be considered on a case- Earnhardt v. Kerry Earnhardt, Inc., 864 F.3d 1374, 123
by-case basis. The Federal Circuit found that the commercial U.S.P.Q.2d 1411 (Fed. Cir. 2017). The Federal Circuit
context of the FIRST TUESDAY mark demonstrated that a vacated the TTAB’s decision dismissing Teresa Earnhardt’s
consumer would immediately understand the intended mean- (Earnhardt) opposition to a trademark application iled by
ing of FIRST TUESDAY, and, as such, the mark was less of a Kerry Earnhardt, Inc. (KEI). KEI was cofounded by the son
source identiier and more of a descriptive feature of the goods of Dale Earnhardt, the professional race car driver, and iled
and services. Thus, the Federal Circuit afirmed the TTAB’s for the mark EARNHARDT COLLECTION for “furniture”
refusal to register the FIRST TUESDAY mark. and “custom construction of homes.” Earnhardt (the widow
of Dale Earnhardt) asserted a likelihood of confusion with her
Likelihood of Confusion federal trademark registrations for DALE EARNHARDT in
In re i.am.symbolic, LLC, 866 F.3d 1315, 123 U.S.P.Q.2d various classes and her common law rights in EARNHARDT
1744 (Fed. Cir. 2017). i.am.symbolic (Symbolic) appealed and DALE EARNHARDT. Earnhardt also asserted that KEI’s
the TTAB’s decision afirming the PTO’s refusal to regis- EARNHARDT COLLECTION mark was primarily merely a
ter the mark I AM on the ground of a likelihood of confusion surname under Section 2(e)(4) of the Lanham Act. The TTAB
with registered marks. The Federal Circuit afirmed. dismissed the opposition on both counts.
Symbolic’s predecessor-in-interest, William Adams (Adams), Earnhardt appealed the TTAB’s decision that EARN-
iled trademark applications for the mark I AM in classes 3, HARDT COLLECTION was not primarily merely a
9, and 14. The examining attorney refused registration on the surname. The Federal Circuit determined it was not clear
ground of likelihood of confusion with previously registered whether the TTAB’s decision properly applied In re Hutchin-
marks. In response, Adams amended the descriptions of goods to son Technology Inc. Under Hutchinson, the EARNHARDT
include the statement: “associated with William Adams, profes- COLLECTION mark must be considered in its entirety rather
sionally known as Will.i.am” (the “will.i.am restriction”) at the than considering the mark as two separate terms. In doing
end of its listing of goods in each class. The examining attorney so, the relative distinctiveness of the second term, COL-
maintained the rejections, and the TTAB afirmed. LECTION, had to be determined, in particular, whether the
Symbolic argued that the TTAB erred in its likelihood of term was merely descriptive of KEI’s goods and services.
confusion analysis by holding that the will.i.am restriction was Because the TTAB’s decision was unclear as to the inding
“precatory” and “meaningless,” therefore not properly consid- as to whether the term, COLLECTION, was merely descrip-
ering it in certain DuPont factors. The Federal Circuit noted tive, the Federal Circuit determined that the TTAB’s analysis
that the cited registrations did not include any express limita- was deicient. Additionally, under Hutchinson, the TTAB also
tions, and such limitations could not be read into unrestricted had to determine whether adding the additional term, COL-
prior-iled registrations or applications. The Federal Circuit went LECTION, to the surname altered the primary signiicance of
through the DuPont factors, explaining why the will.i.am restric- the mark as a whole to the purchasing public. The case was
tion did not suficiently distinguish the mark from registrants’ vacated and remanded to clarify the TTAB’s indings.
John C. Gatz is a member of the irm Nixon Peabody in Chicago, Illinois. Column contributors include the following writers: Copyrights:
Zachary J. Smolinski, Smolinski Law PC; Michael N. Spink, Brinks, Hofer, Gilson & Lione; Mark R. Anderson, Akerman LLP. Patents: Cynthia K.
Barnett, Johnson & Johnson; R. Trevor Carter, Daniel M. Lechleiter, and Andrew M. McCoy, Faegre Baker Daniels LLP; Robert W. (Bill) Mason,
CaptureRx; Peter J. Prommer, Nixon Peabody LLP. Trade Secrets: R. Mark Halligan, FisherBroyles LLP. Trademarks: Janet M. Garetto and
Elizabeth W. Baio, Nixon Peabody LLP; Amy L. Sierocki.
commenced or prosecuted against one of the United States by Citizens and the same parties”); Biomedical Patent Mgmt. Corp. v. Cal.,
of another State, or by Citizens or Subjects of any Foreign State.”). Dep’t of Health Servs., 505 F.3d 1328, 1339 (Fed. Cir. 2007) (same).
11. Nos. IPR2016-01274, -01275 & -01276, Paper No. 19 25. Wilson Sonsini Goodrich & Rosati represents Mylan Phar-
(P.T.A.B. Jan. 25, 2017). maceuticals Inc., a petitioner, in this matter.
12. Id. at 39. 26. Press Release, Allergan plc, Allergan and Saint Regis Mohawk
13. Id. at 5–8 (citing Fed. Mar. Comm’n v. S.C. Ports Auth., 535 Tribe Announce Agreements Regarding RESTASIS® Patents (Sept. 8,
U.S. 743, 753–61 (2002)). 2017), https://www.allergan.com/news/news/thomson-reuters/
14. Id. at 24. allergan-and-saint-regis-mohawk-tribe-announce-agr.
15. Id. at 3 (citing Vas-Cath, Inc. v. Curators of the Univ. of Mo., 27. Id.
473 F.3d 1376, 1383 (Fed. Cir. 2007)). 28. Id.
16. Id. at 25, 27. 29. Katie Thomas, How to Protect a Drug Patent? Give It to a
17. NeoChord, Inc. v. Univ. of Md., Balt., No. IPR2016-00208, Native American Tribe, N.Y. Times, Sept. 8, 2017, https://www.nytimes.
Paper No. 28 (P.T.A.B. May 23, 2017). com/2017/09/08/health/allergan-patent-tribe.html?mcubz=0&_r=0.
18. Id. at 19–20. 30. Jan Wolfe, Tech Entity Has Tribal Pat-
19. No. IPR2016-01914, Paper No. 36 (P.T.A.B. July 13, 2017). ent Deal Similar to Allergan’s, Reuters (Sept. 12, 2017),
20. Id. at 15. https://www.reuters.com/article/us-allergan-patents/
21. 136 S. Ct. 2131, 2134 (2016). tech-entity-has-tribal-patent-deal-similar-to-allergans-idUSKCN1BN35X.
22. Id. at 2136. 31. Kiowa Tribe of Okla. v. Mfg. Techs., Inc., 523 U.S. 751, 756 (1998).
23. Covidien LP v. Univ. of Fla. Research Found., Nos. IPR2016- 32. Thomas, supra note 29.
01274, – 01275 & – 01276, Paper No. 19, at 26 n.4 (P.T.A.B. 33. Richard Torczon, Sovereign Immunity: A Wake-Up Call for
Jan. 25, 2017). USPTO Director?, Law360 (Mar. 3, 2017), https://www.law360.
24. See A123 Sys. Inc. v. Hydro-Quebec, 626 F.3d 1213, 1219– com/articles/897972.
20 (Fed. Cir. 2010) (holding immunity waiver “does not extend to an 34. See Oil States Energy Servs., LLC v. Green’s Energy Grp., LLC,
entirely separate lawsuit, even one involving the same subject matter 639 F. App’x 639 (Fed. Cir. 2016), cert. granted, 137 S. Ct. 2239 (2017).
art includes evidence relevant to the inding of whether there is a teaching, 25. Id. at 1384–85.
motivation, or suggestion to select and combine the references relied on as 26. Id.
evidence of obviousness.” (citation omitted)). 27. 848 F.3d 987, 991 (Fed. Cir. 2017).
10. U.S. Patent & Trademark Office, Manual of Patent 28. Apple, Inc. v. PersonalWeb Techs., LLC, No. IPR2013-00596,
Examining Procedure (MPEP) § 2143 (6th ed. Rev. 1, Sept. 1995) 2015 Pat. App. LEXIS 3518, at *18 (P.T.A.B. Mar. 25, 2015).
(“To establish a prima facie case of obviousness . . . there must be 29. Id.
some suggestion or motivation, either in the references themselves 30. PersonalWeb, 848 F.3d at 993–94.
or in the knowledge generally available to one of ordinary skill in 31. Id. at 991–92 (quoting KSR Int’l Co. v. Telelex Inc., 550
the art, to modify the reference or to combine reference teachings. U.S. 398, 418–19 (2007)).
. . . The teaching or suggestion to make the claimed combination . . . 32. In re Van Os, 844 F.3d 1359, 1361–62 (Fed. Cir. 2017)
must both be found in the prior art, not in applicant’s disclosure.”). (rejecting the notion that, without further discussion, the combi-
11. See KSR, 550 U.S. at 419. nation of two references would have been “intuitive”); see also
12. Id. at 415, 417–18. Ex parte Pappone, No. 2014-009427, 2017 Pat. App. LEXIS 2074
13. U.S. Patent & Trademark Office, Manual of Patent (P.T.A.B. Feb. 10, 2017) (applying Van Os to ind the examiner’s
Examining Procedure (MPEP) § 2143 (8th ed. Rev. 6, Sept. 2007). rationale for a proposed modiication to be insuficient).
14. Id. 33. Van Os, 844 F.3d at 1360–61.
15. 842 F.3d 1376 (Fed. Cir. 2016). 34. Id. at 1361.
16. Id. at 1379–80; see also Synopsys, Inc. v. Mentor Graphics 35. Id.
Corp., 814 F.3d 1309, 1322 (Fed. Cir. 2016). 36. In re Schweickert, 676 F. App’x 988 (Fed. Cir. 2017)
17. NuVasive, 842 F.3d at 1382. (nonprecedential).
18. Id. at 1384–85. 37. Arendi S.A.R.L. v. Apple Inc., 832 F.3d 1355, 1366–67 (Fed. Cir.
19. Medtronic, Inc. v. NuVasive, Inc., No. IPR2013-00506, 2015 2016) (“Because the Board’s presumption that adding a search for phone
Pat. App. LEXIS 2496 (P.T.A.B. Feb. 13, 2014). numbers to Pandit would be ‘common sense’ was conclusory and unsup-
20. Id. at *13. ported by substantial evidence, the missing limitation is not a ‘peripheral’
21. Id. at *15. one, and there is nothing in the record to support the Board’s conclusion
22. Id. that supplying the missing limitation would be obvious to one of skill in
23. NuVasive, 842 F.3d at 1384. the art, we reverse the Board’s inding of unpatentability.”).
24. Id. 38. In re NuVasive, Inc., 842 F.3d 1376, 1383 (Fed. Cir. 2016).
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
Navigating Continued from page 52
pending. Will an earlier-issued patent lose its PTA if a later in lieu of a stand-alone improvement application. For example,
patent in the same family issues with similar claims? Are lon- the 20-year term of a CIP is the same as that of its parent. And
ger terms in pre-URAA patents at risk due to later issuing a previously published parent disclosure acts as prior art to the
post-URAA ilings? Because applicants cannot fully control newly added subject matter, regardless of whether it is iled in
examination speed, it can be dificult to foresee how to arrange a CIP or a new, stand-alone application. Cases such as Pizer,
claims between different applications during examination. Searle, and Janssen also make clear that a CIP may not protect
Nonetheless, there are some practices that may help in avoid- against double patenting the way a divisional does.
ing losses of previously awarded patent terms due to ODP.
Learn to Love Restriction Requirements
How to Split Claims between Applications Patent examiners have wide discretion to issue restriction
Generally, it is helpful to be aware of which types of applica- requirements. While applicants often dislike having origi-
tions in a portfolio tend to have longer examinations, and thus nal claim sets broken up, iling various types of claims in an
longer terms due to PTA. Often the longest examinations occur original application may provoke restriction by claim type.
in the irst-issued case in a family, in part because the USPTO Thus, if examination on one set of subject matter takes a long
may not quickly begin examination. Also, in a irst case, the time or requires appeal, resulting in a long PTA, there is less
examiner and applicant may spend more time searching for the chance of that PTA award being disturbed by later patent
right claim scope and language to confer patentability. In con- issuances in the family. Moreover, applicants should consider
trast, an examiner might quickly consider later-iled cases that initiating further restrictions in subsequently iled applica-
rely on claim language and scope agreed upon in the parent. tions so that lines between claim groups remain clear.
A irst patent in a family with a long PTA can be a problem
if the applicant later wishes to ile a continuation application Consider Patent Ownership
with similar claims. If the parent’s claims are, to maintain valid- Finally, applicants should consider ownership issues. If an
ity, later terminally disclaimed over those of a continuation, the ODP rejection is made during examination or reexamina-
parent may lose most or all of its PTA. Thus, applicants might tion on a patent with overlapping inventors, it can be obviated
wish to consider iling foreseeable further claims, and particu- by a terminal disclaimer. But the applicant must agree to
larly additional narrow claims, in a irst application instead of keep the two patents or applications under common owner-
in a continuation. And applicants may wish to focus continuing ship.45 Collaborators may help avoid later delays in issuance
examination on divisional applications where possible. by reaching early agreement on how they will handle patent
ownership in the event of a terminal disclaimer.
Watch Out for Appeals
A successful appeal decision on at least one claim can lead to Consider Obviousness-Type Double Patenting as a Basis for
lengthy PTA because of backlogs at the PTAB.44 If the success- Invalidity
fully appealed patent contains claims found patentably indistinct ODP also merits consideration when conducting diligence relating
from those of a continuation or improvement patent, that lengthy to, for example, licensing, acquisition, or inancing. For instance,
PTA could be at risk. Thus, it may be helpful to carefully review one should consider whether any earlier-issued, later-expiring
the claims of an application to be appealed against those in other patents in a family could be found invalid for ODP in view of
co-pending and intended future applications. For example, add- later-iled, earlier-expiring family members or other applications
ing narrow claims to the case on appeal rather than submitting having nondistinct claims. Licensing negotiations, in particular,
them in a continuation may allow the additional claims to enjoy can be greatly impacted by concerns regarding the patent term.
a longer term afforded to the successfully appealed patent.
Conclusion
Yet Another Reason Not to File a CIP As of the drafting of this article, practitioners remain in a
As seen above, ODP cannot occur between divisional and state of uncertainty about the scope of ODP and how it will
parent patents protected under the § 121 safe harbor. But the impact patent terms. The Federal Circuit’s decisions in Jans-
Federal Circuit might continue to narrowly deine the scope sen may greatly impact future prosecution strategies. n
of a “divisional application” under § 121 to exclude CIPs
and continuations even if they are explicitly iled in response Endnotes
to a restriction requirement with claims consonant with that 1. See, e.g., In re Hubbell, 709 F.3d 1140, 1145 (Fed. Cir. 2013).
restriction. Thus, applicants should be diligent in initiating 2. Id.
restriction requirements in parent applications and in il- 3. See In re Longi, 759 F.2d 887, 892 (Fed. Cir. 1985).
ing new applications, before examination, as divisionals (in 4. 35 U.S.C. § 253(b); 37 C.F.R. § 1.321.
name) with claims amended to be consonant with the restric- 5. 37 C.F.R. § 1.321(b)–(d).
tion. Consider also telephoning the examiner to ensure that 6. See, e.g., Bayer AG v. Carlsbad Tech., Inc., 298 F.3d 1377 (Fed.
demarcation lines in restrictions are clear and maintained. Cir. 2002) (allowing amendment of a terminal disclaimer because rel-
While the CIPs in the Janssen appeals were iled before the evant changes in law were unforeseeable when the disclaimer was iled);
URAA, there are, since the URAA, few reasons to ile a CIP Japanese Found. for Cancer Research v. Rea, No. 1:13-cv-412, 2013
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
WL 3894156 (E.D. Va. July 26, 2013) (allowing withdrawal of a termi- 22. Brief for Plaintiffs-Appellants, supra note 20, at 2–3.
nal disclaimer because the applicant had not properly authorized iling); 23. Id. at 12.
President & Fellows of Harvard Coll. v. Rea, No. 1:12-cv-1034, 2013 WL 24. Id. at 37–44.
2152635 (E.D. Va. May 15, 2013) (prohibiting withdrawal of terminal 25. Janssen Biotech, Inc. v. Celltrion Healthcare Co., 211 F.
disclaimer where the applicant had not paid the required iling fee). Supp. 3d 364 (D. Mass. 2016); Ex parte Janssen Biotech, Inc., No.
7. Janssen Biotech, Inc. v. Celltrion Healthcare Co., Ltd., No. 2016-006590 (P.T.A.B. Nov. 4, 2016).
17-1120 (Fed. Cir. iled Jan. 26, 2017); In re Janssen Biotech, Inc., 26. See Janssen, 211 F. Supp. 3d at 368.
No. 17-1257 (Fed. Cir. iled Feb. 28, 2017). 27. See Brief for Plaintiffs-Appellants, supra note 20, at 15–18.
8. See, e.g., In re Longi, 759 F.2d 887, 892 (Fed. Cir. 1985); Eli 28. See id.
Lilly & Co. v. Barr Laboratories, Inc., 251 F.3d 955 (Fed. Cir. 2001).] 29. Id. at 17.
9. 35 U.S.C. § 154(a)(2) (providing that the term of a continuing 30. Ex parte Janssen, No. 2016-006590.
application is 20 years from the iling of the irst priority application 31. See id.; Janssen, 211 F. Supp. 3d 364.
iled under 35 U.S.C. § 120, 121, or 365(c)). 32. 518 F.3d 1353 (Fed. Cir. 2008).
10. Id. § 154(b). 33. Id. at 1361–62.
11. 753 F.3d 1208 (Fed. Cir. 2014). 34. Id. at 1362.
12. Under 35 U.S.C. § 156, delays in regulatory approval may 35. Id. at 1359.
separately extend the patent term. 36. Id.
13. Gilead, 753 F.3d at 1210. 37. 580 F.3d 1340 (Fed. Cir. 2009).
14. Id. at 1217. 38. Opening Brief for Janssen Biotech, Inc. & New York Uni-
15. Id. at 1215. versity at 28–31, In re Janssen Biotech, Inc., No. 17-1257 (Fed. Cir.
16. Id. Feb. 28, 2017).
17. 764 F.3d 1366 (Fed. Cir. 2014). 39. See id.
18. Magna Elecs., Inc. v. TRW Auto. Holdings Corp., No. 1:12- 40. 790 F.3d 1349 (Fed. Cir. 2015).
cv-654, 2015 WL 11430786 (W.D. Mich. Dec. 10, 2015). 41. Id. at 1354–55.
19. No. 17-1120 (Fed. Cir. iled Jan. 26, 2017). 42. Opening Brief for Janssen Biotech, Inc. & New York Univer-
20. See Brief for Plaintiffs-Appellants at 10, Janssen, No. sity, supra note 38, at 30–33.
17-1120 (Fed. Cir. Jan. 26, 2017). 43. Id. at 26–29.
21. Janssen Biotech, Inc. v. Celltrion Healthcare Co., 210 F. 44. See 35 U.S.C. § 154(b)(1)(C).
Supp. 3d 278, 279–280, 281 (D. Mass. 2016). 45. 37 C.F.R. § 1.321(b)–(d).
14. In re Ferris Corp., 59 U.S.P.Q.2d 1587 (T.T.A.B. 2000). 32. See In re Pohl-Boskamp GmbH & Co., 106 U.S.P.Q.2d 1042,
15. In re Howard S. Leight & Assocs., 39 U.S.P.Q.2d 1058 1052 (T.T.A.B. 2013).
(T.T.A.B. 1996). 33. Id.
16. Newborn Bros. & Co. v. Dripless, Inc., No. 113471, 2002 34. Id.
T.T.A.B. LEXIS 537 (Aug. 16, 2002). 35. 79 U.S.P.Q.2d 1639 (T.T.A.B. 2006).
17. In re Shuttsco, Inc., 54 U.S.P.Q.2d 1055 (T.T.A.B. 2000). 36. Id. at 1651.
18. Christian Louboutin S.A. v. Yves Saint Laurent Am., Inc., 37. Pohl-Boskamp, 106 U.S.P.Q.2d at 1052.
778 F. Supp. 2d 445, 448 (S.D.N.Y. 2011), rev’d in part, 696 F.3d 38. Registration No. 3,155,702 (Oct. 17, 2006). This registration has
206 (2d Cir. 2012). since been canceled because the registrant did not renew the registration.
19. Id. at 449–50. 39. 529 U.S. 205, 216 (2000).
20. Id. at 451. 40. Registration No. 3,250,178 (June 12, 2007).
21. Louboutin, 696 F.3d at 228–29. 41. Registration No. 3,348,363 (Dec. 4, 2007).
22. Id. at 223 (quoting Qualitex Co. v. Jacobson Prods. Co., 514 42. Registration No. 3,896,100 (Dec. 28, 2010).
U.S. 159, 161 (1995)). 43. This registration has since been canceled because the regis-
23. Id. at 220. trant did not renew the registration.
24. Id. at 222. 44. This registration has since been canceled because the regis-
25. In re Clarke, 17 U.S.P.Q.2d 1238 (T.T.A.B. 1990). trant did not renew the registration.
26. Id. at 1239. 45. TMEP, supra note 5, § 1202.14.
27. Id. 46. 59 U.S.P.Q.2d 1688, 1692–93 (T.T.A.B. 2001).
28. Id. 47. Id. at 1693.
29. Id. at 1239–40. 48. TMEP, supra note 5, § 1202.14.
30. Id. at 1239. 49. Id.; see Upper Deck, 59 U.S.P.Q.2d at 1690–91.
31. Id. at 1239–40. 50. Two Pesos, Inc. v. Taco Cabana, Inc., 505 U.S. 763, 776 (1992).
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
Valuable ADR Resources
for Patent Attorneys
Patent Neutral
Expanding Use of ADR for Settlement
of Patent Disputes at the PTAB
David L. Newman
PC 5370232
$89.95 List Price ADR Advocacy, Strategies,
ADR Advocacy,
$69.95 ABA-IPL Members Strategies, and Practices and Practices
For Intellectual Property and Technology Cases
PC 5370229
$89.95 List Price
$74.95 ABA-IPL Members
@ABAPublishing
Order Today! ShopABA.org 800-285-2221 @ShopABA
ABAPublishing
Published in Landslide® magazine, Volume 10, Number 3, a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
EASY WAY TO UPDATE YOUR ABA MEMBER PROFILE
Take two minutes to update your contact information in your ABA member proile so that you can continue receiving ABA-IPL
Section beneits including Landslide® magazine six times annually in both print and digital versions.
Published in Landslide® magazine, Volume 10, Number 3 , a publication of the ABA Section of Intellectual Property Law (ABA-IPL), ©2018 by the American Bar Association. Reproduced with permission. All rights reserved.
This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.